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Abstract: Seafood, deﬁned here as marine and freshwater ﬁsh and shellﬁsh, is recognized as a healthy food choice
because it is a low-fat protein source that provides long-chain omega-3 fatty acids important for early development along
with eye and heart health. However, seafood is also known to contain certain contaminants, such as methylmercury
and persistent organic pollutants, which can have harmful effects on human health and development. In order to limit
exposure to contaminants while maximizing the beneﬁts of seafood consumption, a number of quantitative and qualitative
risk-beneﬁt analyses have been conducted for seafood consumption. This review paper provides a brief background on
risk-beneﬁt analysis of foods, followed by a discussion of the risks and beneﬁts associated with ﬁsh consumption. Next,
risk-beneﬁt analyses are reviewed in an historical context. While risk-beneﬁt analysis consists of three main elements
(that is, assessment, management, and communication), this review will primarily focus on risk-beneﬁt assessments.
Overall, most studies have found that the beneﬁts far outweigh the risks among the general population, especially when
a variety of ﬁsh is consumed at least twice per week. However, for certain populations (for example, pregnant women
and young children) a more targeted approach is warranted in order to ensure that these groups consume ﬁsh that are
low in contaminants but high in omega-3 fatty acids. The potentially harmful unintended consequences of risk-beneﬁt
communication on the general population and certain groups are also discussed.
Introduction
Probably no food category has lent itself more to a risk-beneﬁt
comparison than seafood. While much of this has been played
out in the popular press, the science of risk-beneﬁt analysis has
steadilyimprovedandhashelpeddecision-makersandgovernment
agencies develop consumption guidelines that inﬂuence individ-
ual consumption patterns as well as food policy. Seafood, deﬁned
here as ﬁsh and shellﬁsh from marine or fresh water, farmed or
wild, has been an important part of the human diet for a long
time and now represents 16.7% of the global population’s animal
protein intake. In 2009, worldwide production of seafood reached
145millionmetrictons(MMT),dividedbetweencaptureﬁsheries
at 90 MMT and aquaculture at 55.1 MMT (FAO 2009). Intake
of seafood and long-chain fatty acids of marine origin has been
associated with many beneﬁts, such as reduced risk of coronary
heart disease (CHD) and improved neurodevelopment; however,
there are also several contaminants present in seafood, such as
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methylmercury (MeHg) and persistent organic pollutants (POPs),
that have been associated with adverse health effects. In order
to address this dilemma, numerous studies have been published
examining various aspects of the risks and beneﬁts of seafood con-
sumption (see Appendix A). Health organizations worldwide have
also released guidance values and advisories to help consumers
manage risks and maximize beneﬁts. The purpose of this review
is to provide a historical overview of risk-beneﬁt analysis work
that has been carried out thus far regarding seafood consumption.
This will include a discussion of the identiﬁcation and characteri-
zation of the health effects of seafood and risk-beneﬁt assessments
related to seafood. Risk-beneﬁt management and communication
advisories will also be discussed. In order to familiarize the reader
with the common terms and methods that will be discussed, an
initial overview of risk-beneﬁt analysis of food is provided.
Methods of Risk-Beneﬁt Analysis of Food
Risk analysis is a well-established ﬁeld that is comprised of
3 major elements: risk assessment, risk management, and risk
communication (FAO/WHO 1997). The risk assessment aspect
involves hazard identiﬁcation, hazard characterization (that is,
dose-response assessment), exposure assessment, and risk charac-
terization. Risk management and communication are often per-
formed by public health organizations and include risk evaluation,
option assessment, option implementation, monitoring and re-
view, and dissemination of information (FAO/WHO 1997). Tra-
ditionally, analysis of risks in foods has been carried out by toxi-
cologists, while nutritionists have evaluated the beneﬁts making a
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Figure 1–Major steps in risk-beneﬁt assessment, as recommended by the EFSA Scientiﬁc Committee and based on the discussions of the EFSA scientiﬁc
colloquium on risk-beneﬁt analysis of foods. Risks and beneﬁts are ﬁrst assessed separately and then the results of the 2 assessments are compared in
the ﬁnal stage of risk-beneﬁt assessment, termed “risk-beneﬁt comparison.” Figure modiﬁed from Barlow and others (2010).
combined risk-beneﬁt analysis difﬁcult (Fransen and others 2010).
When a food exerts both positive and negative effects on health,
it becomes important for risk managers to be able to assess both
the beneﬁts and the risks (Barlow and others 2010). Despite the
importance of risk-beneﬁt analysis of foods, there is currently no
scientiﬁc consensus regarding the underlying methodology and
general principles for this type of analysis (EFSA 2006; Barlow
and others 2010; Fransen and others 2010). However, there is
increased interest and recognition regarding the importance of
risk-beneﬁt analysis of foods, and scientists at the European Food
Safety Authority (EFSA) have proposed a framework based on
risk analysis that incorporates risk-beneﬁt assessment, risk-beneﬁt
management, and risk-beneﬁt communication (EFSA 2006).
An EFSA Scientiﬁc Committee recently presented a guidance
document outlining a methodology for risk-beneﬁt assessments of
food (Barlow and others 2010). They recommended that risk-
beneﬁt assessments be comprised of 3 elements: risk charac-
terization, beneﬁt characterization, and risk-beneﬁt comparison
(Figure 1). The Committee outlined 4 steps on the beneﬁt as-
sessment side that were designed to mirror those involved in risk
assessment:identiﬁcationofpositivehealtheffects/reducedadverse
effects, characterization of those health effects (dose-response as-
sessment), exposure assessment, and characterization of beneﬁts.
The identiﬁcation of risks or beneﬁts involves the description
of adverse or positive health effects of the food or food com-
ponents based on human observational or occupational studies,
animal model studies, or in vitro studies. During health effect char-
acterization, a dose-response curve is developed that describes
the relationship between these effects and intake of the food or
food component. This step often results in the establishment of a
health-based guidance value, such as a tolerable daily intake (TDI)
for a hazardous compound or a reference daily intake (RDI) for
a beneﬁcial compound. The intake of the compounds from foods
is estimated during the exposure assessment step, based on food
consumption data obtained from food frequency questionnaires,
food diaries, food surveys, and so on. Next, risks or beneﬁts can be
characterized by combining the dose-response relationship with
exposure assessment to evaluate the probability of a health risk or
beneﬁt occurring in response to intake of a speciﬁc food or food
compound. The results of the separate risk and beneﬁt assessments
can then be compared in the ﬁnal stage of risk-beneﬁt assessment,
termed "risk-beneﬁt comparison." This assessment should be car-
ried out for the general population and for any subpopulations that
show increased sensitivity to the food or food component(s) being
evaluated. All risk-beneﬁt assessments should include recognition
of the assumptions, uncertainties, strengths, and weaknesses of the
method. Recently, another approach to risk-beneﬁt assessment of
foods was presented by Fransen and others (2010). The authors
were in general agreement with the approach proposed by EFSA
scientists, with the exception that their tiered approach inserted a
number of "stop" points, where a decision is made as to whether
or not the assessment should be continued, and they recommend
conducting the exposure assessment prior to characterization of
health effects. The advantage of conducting an exposure assess-
ment early on is to ﬁrst determine whether or not current levels
of exposure (or lack of exposure) are of concern prior to carry-
ing out an extensive literature search and dose-response modeling
during the health effects characterization step.
In addition to providing a framework for risk-beneﬁt assess-
ment of foods, EFSA scientists also outlined 3 different levels of
risk-beneﬁt assessments that might be considered in a stepwise
approach: (1) separate assessments for risks and beneﬁts to deter-
mine whether the risks far outweigh the beneﬁts or vice versa,
(2) assessments of risks and beneﬁts using common metrics that
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express risks and beneﬁts in the same unit and can be directly
and quantitatively compared, and (3) assessments of risks and ben-
eﬁts using composite metrics (Barlow and others 2010). Some
examples of common metrics include estimates of the proportion
of the population that is not within the health-based guidance
value or estimates of the incidence of disease or mortality oc-
curring at a certain exposure level and the impact of changing
that exposure level. On the other hand, composite metrics, such
as disability-adjusted life years (DALYs) and quality-adjusted life
years (QALYs), are designed to integrate increases or decreases in
2 or more of the following components: morbidity, mortality, dis-
ease burden, and quality of life (Barlow and others 2010). QALYs
were originally introduced in 1976 and are an important part of
healthinterventionsandeconomicevaluations byregulatoryagen-
cies. They allow, as part of a cost-effectiveness analysis, the ability
to assess the improvement in quality-adjusted life expectancy that
may be obtained through speciﬁc health intervention (Ponce and
others 2000; Sassi 2006). Similarly, DALYs are used to quantify the
burden of disease across a population, essentially measuring the gap
between the current level of health and an ideal health situation
(WHO 2010). These tools have been applied in risk-beneﬁt anal-
ysis of seafood consumption, as discussed in a later section (Ponce
and others 2000; Cohen and others 2005a; Guevel and others
2008). Consistent with the stepwise approach proposed by EFSA
scientists, the risk-beneﬁt assessment portion of this paper will be
organized to ﬁrst present qualitative research comparing risks and
beneﬁts, followed by studies that used common metrics, and then
studies using composite metrics to examine the risks and beneﬁts
of seafood and its components.
Identiﬁcation and Characterization of the Health
Effects of Seafood
Positive or reduced adverse health effects of seafood
Interestingly, ﬁsh was initially recognized as a healthy food
choice, because it is a low-fat protein source, and not for its
health-promoting lipids (Anderson and Wiener 1995). High-fat
diets were associated with an increased risk of CHD and some can-
cers, and the National Research Council (NRC) recommended
substituting ﬁsh for fatty meats and whole-milk dairy products as
a way of reducing fat and cholesterol intake (NRC 1989). Early
studies with the Greenland Inuits (Bang and Dyerberg 1972, 1980)
and Danish men (Kromhout and others 1985) suggested an asso-
ciation between ﬁsh consumption and reductions in death from
CHD. For example, Kromhout and others (1985) reported a 44%
reduction in CHD death for men consuming 1 to 2 servings (100
to 200 g) of ﬁsh per week compared to men not eating ﬁsh.
Research over the next few decades supported the association be-
tween ﬁsh consumption and reductions in CHD incidence and
mortality (Whelton and others 2004; K¨ onig and others 2005),
and identiﬁed two omega-3 polyunsaturated fatty acids (PUFAs)
that have a major role in these beneﬁcial effects: eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA) (Simopoulos 1991;
Wang and others 2006; Mozaffarian 2008). EPA and DHA can-
not be synthesized in substantial amounts by the human body and
must be obtained through the diet, with the main source being
seafood, especially fatty ﬁsh (Williams and Burdge 2006). Another
omega-3 fatty acid found in plant-based oils, alpha-linolenic acid
(ALA),isaprecursortoEPAandDHAbutisconvertedatverylow
rates in the human body (<10%) (Williams and Burdge 2006). In
addition to reduced CHD risk, a number of other health beneﬁts
have been strongly associated with EPA/DHA intake and ﬁsh con-
sumption and have been characterized in large-scale epidemiolog-
ical studies, reviews, and meta-analyses (Kris-Etherton and others
2002; IOM 2005; Mozaffarian and Rimm 2006). These include
reduced risk of other cardiovascular disease outcomes such as sud-
den death (Wang and others 2006; Mozaffarian 2008) and stroke
(He and others 2004a; Bouzan and others 2005), increased dura-
tion of gestation (IOM 2005), and improved visual and cognitive
development (Fleith and Clandinin 2005; IOM 2005; Brenna and
Lapillonne 2009). Some other health effects that have been associ-
ated with ﬁsh consumption and EPA/DHA include alleviation of
colitis (Hudert and others 2006) and rheumatoid arthritis (Kremer
2000), reduced cognitive decline, dementia, depression, and sui-
cides(Morrisandothers2005;SontropandCampbell2006;Calon
and Cole 2007; van Gelder and others 2007; Hibbeln 2009), and
decreased likelihood of macular degeneration (SanGiovanni and
others 2007). Seafood also contains a number of vitamins (for
example, A, B-complex, and D) and minerals (such as selenium,
iodine, iron, and zinc) that have been linked to various health ben-
eﬁts (Delange and Lecomte 2000; Rayman 2000; WHO 2002).
Selenium in seafood has been evaluated for its potential to exert
protective effects in terms of reducing accumulation of mercury
in ﬁsh (Paulsson and Lundbergh 1989) and in humans (Sepp¨ anen
and others 2000). Dietary intake of selenium has also been re-
ported to be inversely related to MeHg-induced adverse health
effects in rats, although a human study into this relationship was
inconclusive (Choi and others 2008; Ralston and others 2008).
In terms of dose-response relationships, meta-analyses have re-
ported that reduced risks for CHD were found to occur with
intakes of at least 250 mg/d of EPA+DHA, and maximum bene-
ﬁts were found with about 500 mg/d of EPA+DHA (Mozaffarian
and Rimm 2006; Harris and others 2008; Harris and others 2009).
Withregardtoneurodevelopmentalbeneﬁtsofseafoodintakedur-
ing pregnancy, one observational cohort study reported beneﬁcial
effects to children when maternal seafood intake exceeded 340
g (about 3 to 4 servings) per week (Hibbeln and others 2007)
and others have reported increased infant cognition scores when
maternal weekly seafood intake was 1 serving or more (Daniels
and others 2004), 1.5 to 3.5 servings (Oken and others 2008a), or
greater than 2 servings (Oken and others 2005; Oken and others
2008b), compared to mothers not consuming seafood.
Based on the identiﬁcation and characterization of the health
beneﬁts of seafood and EPA/DHA intake, a number of health-
based guidance values and nutritional recommendations have been
developed by various health organizations (Table 1). Scientiﬁc
committees from organizations such as the Institute of Medicine
(IOM), the Food and Agriculture Organization of the United Na-
tions (FAO)/World Health Organization (WHO), and the Dietary
Guidelines Advisory Committee (DGAC) of the U.S. Department
of Agriculture (USDA) and the U.S. Department of Health and
Human Services (HHS) have recommended consumption of 2
servings per week of a variety of seafood (IOM 2005; DGAC
2010) or about 250 mg of EPA + DHA per day (FAO/WHO
2008; DGAC 2010). The American Heart Association (AHA)
recommends that all adults consume ﬁsh (particularly fatty ﬁsh)
twice a week and that patients with CHD obtain 1000 mg of
EPA+DHA per day (Kris-Etherton and others 2003). Other or-
ganizations, such as the International Society for the Study of
Fatty Acids and Lipids (ISSFAL 2004) and the French Food Safety
Agency (AFFSA 2010) have a recommended intake of 500 mg of
EPA + DHA per day for adults. The FAO/WHO expert consulta-
tion also recommended speciﬁc EPA + DHA intakes for pregnant
or nursing women of 300 mg/d, at least 200 mg of which should
be DHA (FAO/WHO 2008).
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Table 1–Health guidance values for beneﬁcial compounds worldwide.
Guidance Target
Compound term Guidance value population Organization/reference
DHA + EPA RI 500 mg/d 1a ISSFAL 2004
RDI 250 mg/d 1c FAO/WHO 2008
RDI 300 mg/d∗ 4a FAO/WHO 2008
RI 1000 mg/d 5 AHA (Kris-Etherton and others 2003)
– 800 mg
EPA + DHA
1b NATO (Simopoulos 1989)
DHA + EPA/seafood RI Two, 113-g servings of seafood per week,
equivalent to about 250 mg/d
1b DGAC 2010
Omega-3 fatty acids from ﬁsh AI 450 mg/d All HCN (Netherlands 2006)
Long-chain omega-3 fatty acids RDA 500 mg/d
250 mg DHA and 500 mg EPA + DHA
1b4b AFFSA (AFFSA 2010)
Fish – Two servings of ﬁsh per week, especially
fatty ﬁsh
1b AHA (Kris-Etherton and others 2003)
PUFA – 500 mg/d long-chain PUFA 1b ADA (Kris-Etherton 2007)
ALA: 10% EPA + DHA – 1.6 g/d approximately 10%
EPA + DHA
1.1 g/d approximately 10%
EPA + DHA
23 IOM 2005a
n-3 PUFAs – 1% to 2% of energy/d 1b WHO (WHO/FAO 2002)
DHA – 200 mg DHA 4c WAPM (Koletzko and others 2007)
∗of which at least 200 mg/d should be DHA.
1. (a) Healthy adults; (b) general adult population; (c) adult males and nonpregnant/nonlactating adult females.
2. Adult men.
3. Adult women.
4. (a) Adult pregnant and lactating females; (b) pregnant women; (c) pregnant and lactating women.
5. Patients with cardiovascular disease.
6. See Appendix B for abbreviations/acronyms.
Table 2–Health guidance values for contaminants worldwide.
Guidance Target
Compound term Guidance value population Organization/reference
MeHg RfD 0.1 µg/kg bw/d 1c EPA 2001; Rice and others 2003
PTDI 0.2 µg/kg bw/d; 0.47 µg/kg bw/d 3; 1b HC (Dabeka and others 2004)
PTWI 0.23 µg/kg bw/d∗ 1c FAO/WHO (JECFA 2003)
MRL 0.3 µg/kg bw/d 1d ASTDR 1999
GL 0.23 µg/kg bw/da;0 . 4 7µg/kg bw/da 2; 4a SACN/COT 2004
Hg in seafood ML 0.5 ppm, 1.0 ppm for six ﬁshd 1 HC (2007)
EU ML 0.5 ppm; 1.0 ppme 1 EC (2006)
AL 1.0 ppm 1 FDA (2011)
Cadmium PTWI 0.83 µg/kg of body wt/da – JECFA 2010
Lead PTWI 3.6 µg/kg of body wt/daf – JECFA 2010
Hexachlorobenzene TDI 0.17 µg/kg bw/d; 0.16 µg/kg bw/d 5; 6 IPCS 1997
Dioxins and dl PCBs PTMIb 2.33 pg TEQ/kg body wt/da – JECFA 2001
PTWI 2 pg TEQ/kg body wt/da 4b SCF 2001a; SCF 2001b
GL 2 pg TEQ/kg bw/d; 8 pg TEQ/kg bw/d 4b; 4a SACN/COT 2004
Dioxins (PCDD/F)i EU ML 4 pg TEQg 1 EC 2006
TDI 1 pg TEQ/kg bw/d FAO/WHO (JECFA 2003)
Dioxins and dl PCBsi EU ML 8 pg TEQg 1 EC 2006
PCBs TDI 0.13 µg/kg bw/d 1 HC (Health Canada 2007)
RFDc 0.02 µg/kg bw/d 1c EPA 1999
CO MRLc 0.02 µg/kg bw/d 1 ATSDR 2009
TDI 0.02 µg/kg bw/d (0.01 for iPCBs) 4c AFSSA 2007
PCBsi TLg 2.0 ppm 1 FDA/EPA (FDA 2011)
aOriginally expressed on a weekly or monthly basis; bAdjusted to TDI here based on 30 d/mo; cOnly in regards to Aroclor 1016, 1248, and 1254; dEscolar, orange roughy, marlin, fresh and frozen tuna, shark,
and swordﬁsh; eFor predatory ﬁsh species; fWithdrawn in 2010, no new PTWI established; gPer gram muscle meat of ﬁsh and ﬁshery products, excluding eel; iIn ﬁsh.
1. (a) All; (b) general population; (c) all (with special groups in mind); (d) all potentially exposed populations.
2. Pregnant women and women who might become pregnant within a year.
3. Children and women of childbearing age.
4. (a) For protection against nondevelopmental adverse effects (that is, increased cancer risk); (b) For protection of developing male reproductive system; (c) For protection of developmental effects.
5. For noncancer effects.
6. For neoplastic effects.
7. See Appendix B for abbreviations/acronyms.
Hazards and negative health effects of seafood
Despitethedemonstratedpositivehealtheffectsofseafood,there
are also several potential hazards (Table 2) that have been found in
seafood, including pathogens, marine toxins, environmental pol-
lutants, and heavy metals (Yasumoto and Murata 1993; Plessi and
others 2001; Storelli and others 2003; Iwamoto and others 2010).
Although the greatest risk to human health is from pathogens
in seafood, this can be overcome through proper cooking, han-
dling, and storage; therefore, negative health effects from seafood
pathogens are not discussed here. The hazards that are generally
considered in risk-beneﬁt assessments are heavy metals, especially
mercury, and POPs. Mercury is released into the environment
from both natural and anthropogenic sources and is converted
into MeHg by aquatic microorganisms (Rasmussen and others
2005). MeHg can bioaccumulate through the aquatic food chain,
resulting in higher levels in large, predatory species such as sharks
and swordﬁsh, and the most common form of human exposure to
MeHg is from ﬁsh consumption (Gunderson 1995). A correction
factor of 0.85 can be applied to measurements to account for the
proportion of MeHg versus total Hg in seafood. MeHg was ﬁrst
recognized as a hazard in seafood as a result of large-scale industrial
poisonings in the 1950s in Minamata Bay, Japan, where recorded
mercury levels in the local seafood reached 36 ppm (Harada 1995;
Eto 2000). A series of 3 additional large-scale poisonings occurred
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in Iraq between 1955 and 1972 due to the consumption of wheat
seeds coated with alkylmercury fungicide, where mercury levels
in maternal hair ranged from 18 to 598 ppm (Bakir and others
1980; Marsh and others 1987; WHO 1990; Watanabe and Satoh
1996). The events of Minamata Bay and Iraq demonstrated the
detrimental effects that organic mercury can have on the nervous
system and the heightened sensitivity of the fetus to high levels of
exposure. While the mothers were only slightly affected, they gave
birth to infants with severe neurological problems (Watanabe and
Satoh 1996). Many of the victims had hair mercury levels above
50 ppm and ﬁsh and shellﬁsh showed a range from 5.61 to 35.7
ppm of Hg. Normal exposure levels to MeHg in the United States
areatamuchlowerlevel;forexample,ameanmercurylevelinhair
of 0.38 ppm has been reported for U.S. women of childbearing
age consuming 3 or more servings of ﬁsh per month (McDowell
and others 2004), and mercury levels in most U.S. commercial ﬁsh
are below 0.5 ppm (FDA 2009c).
In order to examine the effects of low-level, prenatal expo-
sure to MeHg through dietary consumption of seafood, several
large-scale epidemiological studies were conducted in the 1980s
and 1990s (Grandjean and others 1997; Crump and others 1998;
Davidson and others 1998; Myers and others 2003; Daniels and
others 2004; Wieslaw and others 2006); however, the outcomes of
these studies have been inconsistent (Spurgeon 2006). The 2 most
notable are the Faroe Islands study, n = 917 (Grandjean and oth-
ers 1997), and the Seychelles Child Development Study, n = 711
(Myers and others 1995; Davidson and others 1998; Myers and
others 2003), which monitored families for over 10 y, but reported
conﬂicting results. For the purpose of developing health guidance
values for MeHg intake, the maternal hair-mercury concentration
equivalent to a no-observed-effect level (NOEL) or benchmark
dose lower conﬁdence limit (BMDL) for neurobehavioural effects
has been calculated for each study. The calculated values were
12 ppm for the Faroe Islands studies and 15.3 ppm for the Sey-
chellesIslands(JECFA2003).Interestingly,whilebothpopulations
are known for their high-ﬁsh diets, the results of the Faroe Islands
study showed some adverse effects of mercury exposure on neu-
ropsychological dysfunctions (such as with language, attention,
and memory); whereas no adverse effects were observed in the
Seychelles study, with the exception of one outlier. Inhabitants of
the Faroe Islands are also known to consume pilot whale, which
has been found to contain high levels of mercury and polychlo-
rinated biphenyls (PCBs) in edible tissues (Juhlshamn and others
1987; Longnecker and others 2003).
A third cohort study also evaluated scholastic and psychological
tests administered to 6- and 7-y-old children in New Zealand,
although their ﬁndings were highly inﬂuenced by a single child
whose mother’s mercury level was more than 4 times that of any
other women in the study. When this single outlier was removed,
the BMDL for mercury hair concentration was determined to
range from 7.4 to 10 ppm, and a mercury effect was found in
6 out of 26 tests administered. However, when the outlier was
included, there was no signiﬁcant association between mercury
hair concentration and any of the tests. The authors had no reasons
to believe the outlier’s test results or mother’s hair mercury levels
were ﬂawed and could not conclude which set of data was nearer
to the truth (Crump and others 1998). An epidemiological study
conducted more recently in the United States with 135 mother-
infant pairs reported that infant cognition was favorably associated
with increased maternal ﬁsh intake; however, higher maternal hair
mercury levels were associated with lower infant cognition (Oken
and others 2005). Overall, the highest infant cognition scores were
obtained when women consumed 2 or more servings of ﬁsh per
week, but they had hair mercury levels ≤1.2 ppm.
In addition to neurodevelopmental effects, mercury has also
been examined in terms of its adverse cardiovascular effects
(Salonen and others 1995; Ahlqwist and others 1999; Hallgren
and others 2001; Guallar and others 2002; Yoshizawa and others
2002; Virtanen and others 2005), but the results of these stud-
ies have also been inconsistent. For example, Guallar and others
(2002) reported that toenail mercury levels were 15% higher in
684 male patients with myocardial infarction compared to con-
trols, while Yoshizawa and others (2002) reported no signiﬁcant
association between mercury levels in toenails and risk of CHD
for 470 male health professionals with documented cases of CHD,
compared to controls. According to Stern (2005), the strongest
basis for a formal risk assessment of the cardiovascular effects of
MeHg is provided by the study of Salonen and others (1995) who
reported a 2-fold increased risk of acute myocardial infarction and
a 2.9-fold increased risk of cardiovascular death for Finnish men
with hair levels of MeHg ≥ 2.0 ppm.
Focusingonmanagementofrisksassociatedwithneurodevelop-
mental effects, health-based guidance values have been developed
for MeHg by a number of organizations worldwide. The U.S.
Environmental Protection Agency (EPA) developed a reference
dose (RfD) for MeHg of 0.1 µg/kg body weight (bw)/d, which
includes a 10-fold uncertainty factor (Rice and others 2003). RfD
is deﬁned as the daily intake that is likely to be without appreciable
risk of deleterious effects during a lifetime. The RfD for MeHg
was originally calculated based on the Iraq wheat seed poisonings
(Marsh and others 1987) and was later re-assessed taking into con-
sideration epidemiology studies from the Faroe Islands, Seychelles
Islands, and New Zealand (Rice and others 2003). Other guid-
ance values put in place by various health organization are listed
in Table 2. In terms of risk management of MeHg concentrations
in seafood, the U.S. Food and Drug Administration (FDA) set an
action level of 0.5 ppm in 1969, which was adjusted to 1.0 ppm
in 1979 based on data from the Minamata Bay poisoning disaster.
This level corresponds to a daily intake of 0.5 µg/kg bw/d (NRC
2000; Burger and others 2005). Health Canada has set tolerance
limits of 0.5 ppm for most ﬁsh, with the exception of 1.0 ppm for
escolar, orange roughy, marlin, fresh and frozen tuna, shark and
swordﬁsh (Health Canada 2007); and the European Commission
(EC) has set tolerance limits at 0.5 ppm for most ﬁsh and 1.0 ppm
for predatory ﬁsh species (EC 2006).
In 1994, the U.S. FDA advised pregnant women and women of
childbearing age who may become pregnant to limit consumption
of shark and swordﬁsh to no more than one meal per month due
to the mercury levels in these ﬁsh (ASTDR 1999). Other con-
sumers were advised to limit regular consumption of these species
to about 200 g per week and to limit consumption of ﬁsh with
mercury levels below 0.5 ppm to 400 g per week. With regard to
the top 10 species consumed in the U.S., consumption advice was
considered unnecessary because of the low levels of mercury in
these species and because few people eat more than the suggested
weekly limit of 2.2 pounds (1 kg) for the general contamination
level of these species. In 2001 the U.S. FDA updated a previous ad-
visory and singled out infants, small children, pregnant or nursing
mothers, and women who may become pregnant to completely
avoid shark, swordﬁsh, king mackerel, and tileﬁsh; while stating
that, in general, consumers should limit their consumption of all
ﬁsh to no more than 340 g per week. This advisory was found
to reduce target consumers’ consumption by 15% to 30% or 1.4
servings per month, and it was associated with a 21.8% net drop in
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canned ﬁsh consumption among households with young children
(Oken and others 2003; Schwarz and others 2007; Shimshack
and others 2007). In 2004, the U.S. FDA released a joint advi-
sory with the U.S. EPA that targeted pregnant women, women
who might become pregnant, nursing mothers, and young chil-
dren (FDA 2004a). These groups were advised to eat up to 340 g
(2 average meals) of seafood per week of a variety of ﬁsh and
shellﬁsh that are lower in mercury, such as shrimp, canned light
tuna, salmon, pollock, and catﬁsh. As part of the 340 g per week,
they were advised to eat only up to 170 g (1 average meal) of
albacore (“white”) tuna, due to slightly higher levels of mercury
in this species compared to canned light tuna. They were also
advised not to eat 4 types of ﬁsh due to higher levels of mercury:
shark, swordﬁsh, king mackerel, and tileﬁsh. Metals other than
mercury such as lead, manganese, chromium, cadmium, and ar-
senic may also be found in seafood, although studies have shown
that seafood does not seem to be a main route of exposure to these
metals. The geographic source of the ﬁsh is always a factor and
consuming a wide variety of seafood will reduce the risks involved
withthe trace amountofmetals foundin differentspeciesandareas
(IOM 2005).
POPs, such as PCBs and dioxins, have also been identiﬁed as
hazards that are present in seafood. PCBs are a group of 209
congeners that were widely used in a variety of commercial and
industrial applications (Ross 2004). In the late 1960s and 1970s,
concernsoverthehealtheffectsofPCBswereraisedduetopoison-
ing events resulting from the consumption of PCB-contaminated
food in Japan (Masuda and others 1996) and Taiwan (Ross 2004).
Due to these events and the persistence of PCBs in the envi-
ronment, these chemicals were banned in the United States in
1979. Dioxin is a collective term for a group of toxic chemicals
with a similar mechanism of toxicity; it includes 7 congeners of
polychlorinated dibenzodioxins (PCDDs) and 10 congeners of
polychlorinated dibenzofurans (PCDFs). There are also 12 con-
geners of dioxin-like polychlorinated biphenyls (dl PCBs) that the
U.S. EPA includes within the term dioxin (EPA 2010), but they
can be listed separately (SCF 2001a). In Europe, indicator PCBs
(iPCBs) are a set of 7 PCB congeners used to estimate total PCBs
and have shown to be a good predictor of dl PCBs (Babut and
others 2010). For the purposes of this paper, the term dioxin will
refer to the 17 congeners of PCDDs and PCDFs, and the groups
of dl PCBs and iPCBs will be referred to separately. Although
the environmental levels of PCBs and dioxins have been declin-
ing, these compounds are widely distributed and current exposure
levels remain a concern. PCBs and dioxins can bioaccumulate
and have been characterized by the EPA as likely human carcino-
gens. In addition to the potential carcinogenic effects of PCBs and
dioxins, noncancer effects, including changes in hormone lev-
els and fetal development, have been observed at levels of about
10 times above the normal background exposure (EPA 2010). The
most toxic dioxin congener, 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), was classiﬁed as a known human carcinogen in 1997
and accounts for about 10% of the total background dioxin risk
(EPA 2010).
The toxicity of the various PCB and dioxin congeners is cal-
culated relative to the toxicity of TCDD and is expressed as a
toxic equivalent factor (TEF), as established by WHO (Schecter
and others 2001). Most human exposure to dioxins and PCBs
is through the diet, speciﬁcally from animal fats found in meats,
seafood, and dairy products. To calculate the toxicity of a food
due to PCBs and dioxins, the level of each congener in the food is
multiplied by its TEF and the sum is reported as the total dioxin-
like toxic equivalency, or TEQ. As shown in Table 2, limits for
dioxinexposuresrangebetween1and4pgTEQ/kgbw/dforpro-
tection against developmental effects (JECFA 2001; SCF 2001b;
SACN/COT 2004) and for protection against increased cancer
risk, a limit has been set at 8 pg TEQ/kg bw/d (SACN/COT
2004). In general, adult men and women have daily TEQ in-
takes of 2.4 and 2.2 pg/kg bw, respectively. About 9% of dietary
exposure is from ﬁsh and shellﬁsh (Schecter and others 2001), pri-
marily from ﬁsh caught in fresh waters, estuaries, and near-shore
coastal waters rather than the open ocean. The EC has established
a maximum level for dl PCBs and dioxins in seafood of 8 pg TEQ
per g seafood (ppt TEQ) (EC 2006) and the U.S. FDA has set a
tolerance level for PCBs in seafood of 2.0 ppm (FDA 2011). A
review of numerous studies reporting levels of PCBs and dioxins
in a variety of ﬁsh and shellﬁsh reported ranges of 0.5 to 100 ppb
for PCBs and 0.2 to 17 ppt TEQ for dioxins (Mozaffarian and
Rimm 2006), while international averages of dl PCBs and dioxins
in ﬁsh, cephalopods, and crustaceans have been reported to range
from 0.15 to 3.0 ppt TEQ (JECFA 2001; Storelli 2008).
The greatest risk to human health from POPs occurs when
ﬁsh is harvested recreationally from contaminated waters and con-
sumed in large amounts by subsistence anglers, pregnant women,
and young children. While some studies have reported an associ-
ation between prenatal exposure to PCBs and dioxins and child-
hood neurodevelopmental problems (Jacobson and others 1990;
Jacobson and Jacobson 1996; Patandin and others 1999;
Grandjean and others 2001; Ribas-Fito and others 2001; Schantz
and others 2003; Stewart and others 2003; Nakajima and others
2006; Stewart and others 2008), others have not found an effect
(Daniels and others 2003; Gray and others 2005). For example,
Grandjean and others (2001) reported an association between um-
bilical cord PCB concentration and deﬁcits in 2 to 3 out of 17
neuropsychological tests among a cohort of 435 Faroese children.
Interestingly, PCB-associated deﬁcits only occurred in children
that also had higher levels of mercury exposure, indicating a possi-
ble confounding effect. A cohort from the Great Lakes area in the
United States was examined for the relationship between prenatal
PCBs and Neonatal Behavioral Assessment Scale (NBAS) perfor-
manceinbabiesborntowomenconsumingLakeOntarioﬁsh(n=
156). The authors concluded consumption of these contaminated
ﬁsh is associated with lower IQ in children (Lonky and others
1996; Stewart and others 2000; Stewart and others 2003; Stewart
and others 2008). On the other hand, in a series of studies pub-
lished by Daniels and others (2003) and Gray and others (2005)
involving over 1200 mother-child pairs, there was no relation-
ship between prenatal PCB exposure and mental or psychomotor
scores in 8-mo-old infants or IQ scores at 7 y of age.
EPA has developed a set of guidelines to assess the cancer risks of
certain compounds, such as POPs, in the population (EPA 2000,
2005). When making risk assessments, the EPA assumes there is
no “safe” lower threshold for carcinogenic compounds, signify-
ing any exposure may pose some cancer risk. This cancer risk is
expressed as a cancer slope factor (CSF) or cancer potency factor
(CPF) with units of risk expressed in mg carcinogenic agent/kg
bw/d exposure. The initial data are dose-response data acquired
during epidemiological studies or chronic animal bioassays. These
data are then extrapolated to represent the lower doses encoun-
tered by the general public. The EPA has only identiﬁed CSFs for
compounds with enough data to justify development of a value,
such as arsenic, polycyclic aromatic hydrocarbons (PAHs), PCBs,
and dioxins/furans. CSFs can be calculated for both oral and in-
halation exposure; as well as unit risks, for example, data speciﬁc
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for contaminants in a speciﬁc medium (air or water, for exam-
ple) are expressed as risk per one unit of concentration of the
contaminant. Cancer potency is determined by ﬁtting available
dose-response data to standard cancer risk extrapolation models.
The CSF is then estimated as the slope of the linear extrapolation
to the origin drawn from the 95% lower conﬁdence limit in the
low-dose region. This provides a higher estimate of risk and the
actual risk can be much lower than or as low as zero. The CSFs can
then be useful in calculations of daily consumption limits. Most
CSFs for different compounds can be found on EPA’s Integrated
Risk Information System (http://www.epa.gov/IRIS/).
Qualitative Risk-Beneﬁt Assessments
Incorporating the many risks and beneﬁts that have been asso-
ciated with seafood consumption into a risk-beneﬁt assessment is
a challenging task. All studies involving characterization of health
effects have a certain degree of uncertainty and variation that must
be taken into account. Also, inconsistencies among the ﬁndings
of several studies that have investigated the same health endpoint
further complicate the issue. In order to provide a comprehen-
sive assessment that includes consideration of the numerous health
endpoints associated with seafood, several large-scale, qualitative
risk-beneﬁt assessments have been conducted. Many of these have
resulted in speciﬁc seafood consumption recommendations for
the general population and for target populations. For example, at
the request of the National Oceanic and Atmospheric Adminis-
tration (NOAA), the Institute of Medicine (IOM) of the National
Academies put together an expert committee to examine relation-
ships between the risks and beneﬁts of seafood in order to help
consumers make informed choices (IOM 2005). The committee
carried out a 4-part qualitative protocol to assess and balance the
risks and beneﬁts of seafood, involving (1) identiﬁcation of the
magnitude of the risks and beneﬁts, (2) identiﬁcation of risks and
beneﬁts that are important enough to be included in the balanc-
ing process, (3) evaluation of the changes in risks and beneﬁts
associated with different consumption patterns, and (4) balanc-
ing of the risks and beneﬁts to arrive at speciﬁc consumption
guidelines. In order to identify the health beneﬁts of seafood and
EPA + DHA, the committee examined numerous studies and
other systematic reviews by the Agency for Health Research and
Quality (AHRQ) (Balk and others 2004; Schachter and others
2004; Wang and others 2004; Schachter and others 2005). Positive
health effects were examined for a number of areas, including ben-
eﬁts to women during and after pregnancy; duration of gestation
and birth weight; infant and child development; and cardiovascu-
lar disease, cardiovascular mortality, and all-cause morbidity and
mortality. Overall, the greatest evidence for health beneﬁts was
related to reduced risk of cardiovascular disease, greater duration
of gestation, and improved visual and cognitive development asso-
ciated with maternal seafood or EPA/DHA intake. However, the
committee also noted that the average amounts of seafood con-
sumed by the U.S. population are below levels suggested by many
authoritative groups to achieve positive health effects. In terms
of hazards associated with seafood consumption, the committee
conducted an extensive evaluation of the health effects of MeHg
and other metals, such as cadmium; POPs; microbiological agents;
seafood allergens; and naturally occurring toxins. Based on their
review of the evidence, the committee concluded that among
the potential chemical contaminants in seafood, MeHg poses the
greatest concern for adverse health effects, whereas the risk as-
sociated with POPs remains uncertain, and risks associated with
microbial hazards, allergens, and toxins are persistent, yet more
controllable. Due to uncertainties in terms of the ability of the
committee to quantify risk-beneﬁt tradeoffs based on the available
evidence, a qualitative risk-beneﬁt assessment was conducted. Af-
ter balancing the evidence with regard to cardiovascular beneﬁts
and developmental risks and beneﬁts of seafood, 4 target popu-
lations were identiﬁed and speciﬁc consumption guidelines were
developed for these populations. Brieﬂy, the committee stated that
healthy adolescent and adult males and females (who will not be-
come pregnant) may reduce their risk for cardiovascular disease
by consuming seafood regularly, making sure they chose from a
variety of seafood if consuming more than 2 servings per week.
Similar guidelines were given for adult males and females who
are at risk of cardiovascular disease, with the addition that this
group may beneﬁt from including seafood high in EPA and DHA.
The committee stated that the other 2 target populations, females
who are or may become pregnant or who are breast-feeding and
children up to 12 y of age, may beneﬁt from consuming seafood,
especially selections high in EPA and DHA, and they can safely
consume up to 340 g of seafood per week including up to 170 g
of albacore tuna, but that they should avoid large predatory species
such as shark, swordﬁsh, tileﬁsh, or king mackerel.
Another in-depth qualitative risk-beneﬁt assessment of seafood
consumption was conducted by Mozaffarian and Rimm (2006)
from the Harvard School of Public Health and Harvard Med-
ical School. The assessment involved examination of scientiﬁc
publications, government reports, systematic reviews and meta-
analyses related to 4 categories: (1) association between intake
of ﬁsh or ﬁsh oils and reduced risk of cardiovascular events and
mortality, (2) effects of MeHg and ﬁsh oil on early neurode-
velopment, (3) association between MeHg exposure and nega-
tive cardiovascular or neurologic effects in adults, and (4) health
risks of PCBs and dioxins in ﬁsh. The authors focused on hu-
man health studies from randomized trials and large prospec-
tive studies and, when possible, conducted meta-analyses to
better characterize risks and beneﬁts. In terms of cardiovas-
cular outcomes, the assessment showed that intake of about
250 mg/d EPA + DHA, or 1 to 2 servings/wk of ﬁsh high in these
fatty acids, was associated with risk reductions of 36% for CHD
death and 17% for total mortality. However, at higher intakes,
there was little additional risk reduction, suggesting a threshold
for maximum cardiovascular beneﬁts of 250 mg/d EPA + DHA.
For developmental outcomes, the assessment revealed the impor-
tance of DHA for cognitive and visual development, but also
showed the potential negative effects of low-level MeHg exposure
on cognitive development. Based on these ﬁndings and dose-
response relationships, the authors recommended that women of
childbearing age and nursing mothers should consume 2 serv-
ings of seafood per week, with limited intake of selected species
that show elevated mercury levels. The assessment of MeHg and
cardiovascular outcomes in adults revealed uncertainty in terms
of the health effects of low-level exposure among adults. There-
fore, Mozaffarian and Rimm (2006) suggested choosing from a
variety of seafood and noted that adults consuming ≥ 5 serv-
ings/wk should limit intake of high-mercury ﬁsh species. Levels
of PCBs and dioxins were reported to be relatively low in ﬁsh
and the health beneﬁts of seafood intake were found to outweigh
any potential adverse effects from these contaminants. However,
women of childbearing age were advised to check regional risk
advisoriespriortoconsuminglocallycaughtfreshwaterﬁsh.Over-
all, the authors concluded that the beneﬁts of ﬁsh intake ex-
ceed the potential risks for major health outcomes among adults,
and for women of childbearing age, the beneﬁts of modest ﬁsh
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intake, excepting a few selected species, also outweigh the po-
tential risks. They also cautioned that avoidance of ﬁsh due to
confusion surrounding the risks and beneﬁts could lead to subop-
timal neurodevelopment in children and thousands of additional
deaths annually from CHD. Although this risk-beneﬁt assessment
has been criticized for discounting the negative health effects of
MeHg on cardiovascular disease in adults (Stern 2007), studies
examining this topic have reported conﬂicting results, as discussed
in an earlier section, and according to Mozaffarian and Rimm
(2006); even in studies reporting negative effects of MeHg, the
net effect of seafood consumption was still positive.
In Europe, FAO and WHO held an expert consultation in
January 2010 to compare the risks and beneﬁts of seafood con-
sumption, based on a request for scientiﬁc advice from the Codex
Alimentarius Commission (JECFA 2010). The consultation ex-
amined the levels of speciﬁc nutrients and contaminants (that
is, MeHg, dioxins, dl PCBs, and furans) in seafood, as well as
the scientiﬁc literature regarding the risks and beneﬁts of seafood
consumption. This information was used to consider risk-beneﬁt
assessments for certain health endpoints, including sensitive popu-
lations. The consultation compared the beneﬁts of ﬁsh consump-
tion related to neurodevelopment and prevention of cardiovascular
disease with the risks of ﬁsh consumption related to neurodevelop-
ment, cardiovascular disease, and cancer. Overall, the consultation
recognized that ﬁsh was a source of energy, protein, and other
important nutrients, such as DHA and EPA, and that consump-
tion of ﬁsh, especially oily ﬁsh, lowers the risk of CHD mortality
among the general adult population. They did not ﬁnd convinc-
ing evidence of CHD risks from MeHg and determined that the
potential cancer risks of dioxins and dl PCBs were well below
established CHD beneﬁts. With regard to neurodevelopmental
effects of omega-3 intake and MeHg exposure, the consultation
concluded that in most cases maternal ﬁsh consumption lowers
the risk of suboptimal neurodevelopment compared to no mater-
nal ﬁsh consumption. Further, when maternal dioxin and dl PCB
intake is below the provisional tolerable monthly intake (PTMI) of
70 pg/kg bw/mo established by the JECFA, neurodevelopmental
risk was determined to be negligible; however, when intake ex-
ceeds the PTMI, the risk may no longer be negligible. Finally, the
consultation outlined a series of recommendations, including an
emphasis on the beneﬁts of eating seafood in terms of reducing
CHD mortality and improving neurodevelopment, as well as the
development and evaluation of risk management and communica-
tion strategies related to seafood consumption that both minimize
risks and maximize beneﬁts.
In the United States, the 2010 DGAC, which was established
jointly by the Secretaries of the USDA and the U.S. Department
of Health and Human Services, compared the risks and ben-
eﬁts of seafood and recommended speciﬁc guidelines for both
seafood and EPA + DHA intake. Several health endpoints were
considered, including the association between EPA + DHA and
risk of CHD, the association between maternal intake of EPA
+ DHA and health outcomes in infants, as well as an overall
comparison of the risks and beneﬁts of seafood consumption.
Twenty-ﬁve studies published since 2004 were examined in terms
of CHD beneﬁts associated with seafood and EPA + DHA, in-
cluding 6 systematic reviews/meta-analyses (He and others 2004b;
Whelton and others 2004; K¨ onig and others 2005; Mozaffar-
ian and Rimm 2006; Wang and others 2006; Mozaffarian 2008).
DGAC found consistency among these studies and made the con-
clusion that moderate evidence shows that about two 113-g serv-
ingsperweekofseafood(about250mgEPA+DHAperday)isas-
sociatedwithareducedriskofcardiacmortalityfromCHDorsud-
dendeathinindividualswithandwithoutcardiovasculardisease.In
their evaluation of developmental beneﬁts, the DGAC considered
several expert opinions, including the Cochrane Database Sys-
tematic Review (Makrides and others 2006), American Dietetic
Association (ADA) Evidence Analysis (Kaiser and Allen 2008),
and the European Union Perinatal Lipid Intake Working Group
assessment (Koletzko and others 2007), as well as a background
paper that reviewed 23 trials (Brenna and Lapillonne 2009), and 9
additional papers discussing the effects of omega-3 fatty acids on
breast milk composition and infant health outcomes. Overall, the
DGAC concluded that moderate evidence indicated an association
between increased maternal intake (during pregnancy and lacta-
tion) of long-chain omega-3 fatty acids, especially DHA from at
least 2 servings of seafood per week, and increased levels of DHA
in breast milk as well as improved infant health outcomes, such as
visualacuityandcognitivedevelopment.Intheiroverallassessment
of the risks and beneﬁts of seafood, the DGAC examined 9 studies
that have explored a wide range of potential health effects along
numerous health endpoints: 3 quantitative risk-beneﬁt assessment
studies (Guevel and others 2008; Sioen and others 2008; Ginsberg
and Toal 2009), 4 cross-sectional studies (Rawn and others 2002;
Huang and others 2006; Dewailly and others 2007; Verger and
others 2008), 1 meta-analysis (Gochfeld and Burger 2005), the
systematic review from Mozaffarian and Rimm (2006), and the
report from IOM (2005). Based on their review of these studies,
the DGAC concluded that moderate, consistent evidence sug-
gests that the health beneﬁts associated with 2 servings per week
of cooked seafood outweigh the potential risks from MeHg and
POPs exposure, even among women of childbearing age, pregnant
and nursing women, and children ages 12 and under. In agreement
with the IOM report, the DGAC stated that consumers can safely
eat at least 340 g of a variety of seafood every week, provided that
they also follow federal and local advisories and limit consumption
of large predatory ﬁsh. Overall, the DGAC felt that encourage-
ment of seafood consumption in the United States is justiﬁed, as
intake levels continue to be below those recommended for health
by the Committee and by the IOM.
Quantitative Risk-Beneﬁt Assessments
Assessments based on common metrics
Risk-beneﬁt assessments with common metrics include the use
of single outcome measures, like incidences of mortality, morbid-
ity,orexceeding/notmeetinghealth-basedguidancevalues.These
types of assessments are easy to comprehend and have limited data
needs, but they must be interpreted with caution because they
usually only provide some of the information of interest (Fransen
and others 2010). Further, many of these studies do not combine
the risks and beneﬁts into a net health outcome, as do compos-
ite metrics, but can be a useful step in a full risk-beneﬁt analysis
by presenting the information in the same units for comparison.
Risk-beneﬁt assessments that have been carried out for seafood
using common metrics are reviewed in this section.
An early risk-beneﬁt assessment of seafood by Anderson and
Wiener (1995) used a risk tradeoff analysis method to compare the
potential cancer risk of eating ﬁsh to the potential CHD risk of not
eating ﬁsh. The cardiovascular risk of not eating ﬁsh was derived
from the results of Kromhout and others (1985), described earlier,
where consumption of 1 to 14 g ﬁsh/person/d was estimated to
reduce the risk of CHD by 36% and consumption of 15 to 29 g
ﬁsh/person/d was estimated to reduce the risk of CHD by 44%.
The cancer-related risk of eating ﬁsh was estimated by calculating
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potential exposure to 6 carcinogenic compounds with an allow-
able concentration limit set by the FDA and a CSF determined by
the EPA: PCBs, dioxins, dichlorodiphenyltrichloroethane (DDT),
chlordane, dieldrin, and heptachlor. The analysis assumed that all
ﬁsh consumed were contaminated with all 6 compounds at levels
matching the FDA limits of 2.0 ppm (PCBs), 50 ppt (dioxins),
5.0 ppm (DDT), and 0.3 ppm (chlordane, dieldrin, and hep-
tachlor). The CSFs associated with exposure to compounds at
these levels were calculated, assuming an average body weight of
70 kg and chronic exposure over a 70-y lifespan. The results of
this analysis revealed that the lifetime risk of getting cancer for
someone eating 1 g of contaminated ﬁsh per day over the course
of 70 y was estimated at 5.0 × 10−4 (5 in 10000) and consumption
of 20 g of contaminated ﬁsh per day (1.4, 100-g servings/wk) for
70 y was estimated to increase cancer risk to 1 in 100. The overall
risk for cancer for the average American is 25%, so based on these
predictions consumption of 20 g/d of contaminated ﬁsh would
increase the overall cancer risk to 26%. However, the cancer risk
of eating 20-g ﬁsh/d in the United States based on the actual levels
of contaminants in ﬁsh has been estimated to be much less (0.75 in
10000) than the risk of eating contaminated ﬁsh calculated using
the previous assumptions (IOM 1991). On the other hand, at the
time of this study the average total risk of CHD mortality was
35% and the average ﬁsh consumption was 15 g/d. The results of
Kromhout and others indicated that reducing ﬁsh consumption
from 15 to 29 g/d to 0 g/d would increase the risk of dying from
CHD by about 66%, meaning that the total risk of dying from
CHD would be predicted to increase from 35% to 58%. Based
on the results presented here, the cardiovascular beneﬁts of ﬁsh
consumption were determined to far outweigh the carcinogenic
risks, even when ﬁsh contain all 6 carcinogenic contaminants at
the FDA limits and all cancers are assumed to be fatal.
Several studies have been carried out assessing the levels of or-
ganic contaminants in farmed and wild salmon and potential risks
to human health (Hites and others 2004a; Hites and others 2004b;
Foran and others 2005a; Huang and others 2006), with resulting
recommendations to limit consumption of salmon to only 0.2 to
8 meals per month, depending on the harvest location. How-
ever, salmon is a rich source of omega-3 fatty acids and reducing
consumption to these levels would be expected to concomitantly
increasetheriskofcardiovasculardiseaseandmortality,asdiscussed
above. To better understand the overall health effects of altering
consumption levels of farmed and wild salmon, risk-beneﬁt as-
sessments have been conducted by Foran and others (2005b) and
Dewailly and others (2007).
Foran and others (2005b) considered the cancer and noncancer
risks associated with exposure to organic contaminants when
enough salmon is consumed to provide 1 g of EPA + DHA per
day. Levels of organic contaminants and omega-3 fatty acids in
farmed Atlantic salmon and wild Paciﬁc salmon were obtained
from previous work (Hites and others 2004a). Risks were calcu-
lated based on an average body weight of 70 kg and continuous
exposure to contaminants over a 70-y lifespan. Noncancer risk was
calculated for 14 contaminants (including PCBs, hexachloroben-
zene (HCB), chlordane, dieldrin, heptachlor, MeHg, and others)
and was deemed acceptable when the ratio between the cumula-
tive exposure level for all contaminants and the cumulative RfD
for all contaminants was <1. The acceptable cancer risk level re-
sulting from the cumulative analysis of 11 contaminants with CSFs
(including PCBs, 2,3,7,8-TCDD, HCB, chlordane, dieldrin, hep-
tachlor, and others) was set at 1 × 10−5, which is the midpoint
of the acceptable range established by the EPA (1 × 10−4 to 1 ×
10−6). At consumption levels of two 100-g servings per week, the
cumulative noncancer risk from organic contaminants was pre-
dicted to remain within acceptable levels, with the greatest beneﬁt
coming from wild salmon. On the other hand, salmon consump-
tion at these levels was associated with an increased cancer risk,
with a cumulative risk of 8 × 10−5 (that is, 8 in 100000) for
wild salmon and 2.4 × 10−4 for farmed salmon. Based on these
results, Foran and others (2005b) made recommendations to limit
consumption of farmed and wild salmon to 4 or fewer meals per
month, depending on the source of the ﬁsh. However, when the
health outcomes of consuming 1 g EPA + DHA per day were
calculated, the number of lives that would be saved from CHD
mortalitywasreportedtobeabout7100per100000people,which
outweighs the potential risk of cancer by a factor of 300 (farmed
salmon) to 900 (wild salmon). Additional age-adjusted analysis by
Mozaffarian and Rimm (2006) indicated that the CHD beneﬁts
outweigh the cancer risks by 100- to 370-fold for farmed salmon
and 300- to more than 1000-fold for wild salmon. These factors
may be further increased if salmon is consumed at levels that pro-
vide about 250 mg EPA + DHA/d (that is, about 150 g of wild
salmon per week or 100 g of farmed salmon every 2 wk), which
would be predicted to provide similar protection against CHD
mortality as 1 g EPA + DHA/d while reducing lifetime cancer
risk from salmon consumption by about 75%. Further, the levels
of organic contaminants that form the basis of the risk calculations
included skin and disregarded the losses of PCBs that can occur
during cooking, so the actual risks of eating cooked salmon are
predicted to be less than that calculated by Foran (Santerre 2010).
The CSF method used by Foran and others (2005b) to calculate
cumulative cancer risk has been criticized as not being appropri-
ate for the type of carcinogens found in salmon (that is, epigenetic
carcinogens) because it assumes a linear, nonthreshold relation-
ship between risk and low-dose exposure (Dewailly and others
2007). Instead, Dewailly and others used health-based guidance
values for MeHg, PCBs, and dioxins to examine the reproductive
and developmental risks associated with consumption of enough
salmon to provide 500 mg EPA + DHA per day. Atlantic salmon
and rainbow trout samples were collected in Quebec, Canada, and
levels of contaminants and fatty acids were analyzed in skinless,
raw ﬁllets with all subcutaneous or mesenteric fat removed. The
levels of EPA + DHA determined for farmed salmon in this study
were about 4-fold less than those reported by Foran and others
(2005b), and the results indicated that daily intake of 58 to 69 g (or
four to ﬁve, 100-g servings per week) of farmed salmon or trout
would provide 500 mg EPA + DHA. For risk-beneﬁt assessment,
the authors considered the contaminant exposure associated with
consumption of two 180-g meals per week of farmed Atlantic
salmon, which provides about 440 mg EPA + DHA/d. Calcula-
tions were carried out based on 20- to 39-y-old women with an
average body weight of 60 kg. The predicted exposure to con-
taminants at this consumption rate was below the tolerable intakes
established in Canada and by the FAO/WHO in all cases, with
levels of 0.015 µg/kg bw/d for MeHg, 0.012 µg/kg bw/d for
PCBs, and 0.070 pg TEQ/kg bw/d. Although not all dl PCBs
were measured in this study, total TEQ intake was estimated to be
0.28 pg TEQ/kg bw/d, which was based on the assumption that
dioxins make up about 25% of the total TEQ exposure. This pre-
dicted exposure level is well below the FAO/WHO tolerable in-
take of 2.33 pg TEQ/kg body wt/d. Farmed trout showed similar
(for MeHg) or lower (for PCBs or dioxins) levels of contaminants
as compared to farmed salmon and consumption of 360 g/wk
would not be expected to result in excessive exposure. Overall, the
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authors concluded that two 180-g meals per week of farmed
salmon or trout available in North American markets would be
expected to provide sufﬁcient levels of EPA + DHA without con-
cern over the putative health risks.
Combining exposure assessments with health-based
guidance values. A number of studies have assessed the risks
and beneﬁts of seafood by comparing exposure assessments with
health-based guidance values for seafood (for example, TDI, RfD,
or recommended intake). Although this type of study does not
allow for a full quantitative risk-beneﬁt assessment, it can serve
as a valuable ﬁrst step in identifying whether a complete assess-
ment is warranted (Fransen and others 2010). These studies are
generally carried out using either a deterministic (“worst case”
scenario) or probabilistic approach (Cardoso and others 2010).
The latter approach allows for an estimate of the probability of
the target population that is at risk of either exceeding a maxi-
mum safe limit or not reaching a recommended intake level. The
modeling of probability distributions takes into account the vari-
ability of the data and this approach has been increasingly used to
assess contaminants in foods. It is important to note that proba-
bility estimates are highly dependent on the tail behavior of the
distributions, since health-based guidance values tend to be at the
upper or lower range of most individual intakes, and the statistical
tools used for these assessments must be highly rigorous and reli-
able (Cardoso and others 2010). Some important variables to take
into account in both deterministic and probabilistic studies are the
food intake data and the levels of contaminants and nutrients in
these foods. Food intake data are generally obtained through food
consumption surveys such as food frequency questionnaires, 24-h
recall dietary surveys, and one- to seven-day food diaries (Barlow
and others 2010), while contaminants and nutrients in foods are
generally obtained through databases, such as the one described
by Sioen and others (2007a) which pools data from different pub-
lications. However, seafood is a complex food group with many
different categories and species, and food intake data are generally
not speciﬁc with regard to the seafood species consumed. Because
various seafood species are known to contain different levels of
nutrients and contaminants, exposure levels estimated for seafood
in these types of assessments may be associated with a high degree
of uncertainty. Studies that have compared exposure assessments
with health-based guidance values to assess risks and beneﬁts have
been carried out speciﬁcally for consumers in countries such as
France (Cr´ epet and others 2005; Leblanc and others 2006; Verger
and others 2008; Pouzaud and others 2009), Spain (Domingo and
others 2007a), The Netherlands (van der Voet and others 2007),
and Belgium (Sioen and others 2008), as well as on a broader
scale for consumers across Europe (Cardoso and others 2010) and
worldwide (Sioen and others 2009).
Several studies have been devoted to risk-beneﬁt assessments
for French consumers living in coastal regions with high ﬁsh con-
sumption. One such assessment, called the CALIPSO study, was
delegated by the General Food Directorate to the French Institute
for Agronomy Research (INRA) (Leblanc and others 2006). The
CALIPSO study examined dietary patterns among some 1000
French consumers living in 4 coastal regions with high seafood
consumption, evaluated blood and urinary biomarkers associated
with nutrient and contaminant intake for about half of the study
participants, and determined levels of nutrients (omega-3 fatty
acids) and contaminants (6 trace elements and 3 categories of
POPs) in a variety of seafood sampled in the study regions. The
study participants were limited to adults that consumed seafood at
least twice per week and consumption data were obtained with a
food frequency questionnaire that listed 82 ﬁshes, mollusks, crus-
taceans,andseafood-baseddishes.Omega-3fattyacidintakeswere
compared to the French Recommended Daily Allowance (RDA)
of 400 to 500 mg/d for adults and exposure levels to trace ele-
ments and POPs were compared to provisional tolerable intakes
established by the JECFA, when available. The results indicated
that consumption of at least 2 servings of ﬁsh, including some
oily ﬁsh, per week would allow consumers to obtain the RDA
of omega-3 fatty acids. Male and female study participants in the
age range of 18 to 64 y consumed a weekly average of about 630
to 640 g of fresh and frozen ﬁsh, 260 to 270 g of mollusks and
crustaceans, and about 270 to 310 g of other types of seafood,
making total seafood consumption equivalent to about twelve,
100-g servings per week. EPA + DHA intake exceeded 500 mg/d
for 84% of the study participants, with an average level of 1240 ±
960 mg/d (Bemrah and others 2008). However, most of the types
of seafood that contributed strongly to omega-3 fatty acid intake
also accounted for greatest exposure to POPs, particularly salmon,
mackerel, and sardine. In terms of risks, the study found that only
individuals in the highest consumption group had a nonnegligible
risk of exceeding the maximum limits for MeHg, Cd, dioxins,
and PCBs. The average exposure to POPs among all study par-
ticipants was 18.7 ± 19.6 pg TEQ/kg bw/wk for dioxins and
dl PCBs, 0.04 ± 0.06 µg/kg bw/wk for iPCBs, and 2.2 ± 1.8
ng/kg bw/d for PBDEs. Study participants had a 39% probability
of exceeding the provisional tolerable weekly intake (PTWI) for
dioxins and dl PCBs and 72% probability of exceeding the PTWI
for iPCBs. The average exposure level to MeHg from seafood
was 1.5 ± 1.2 MeHg/kg bw/wk, with some 34% of the study
participants exceeding the PTWI established by JECFA (1.6 µg
MeHg/kg bw/wk). None of the study participants exceeded the
PTWIs established for organic tin, arsenic, and lead, and only 8.5%
exceeded that established for Cd. In terms of blood levels of these
trace elements, most subjects (94% to 97%) had levels at or below
the standard level, and women of childbearing age had average
MeHg levels of 2.3 to 3.4 µg/L, which is well below the highest
exposure level at which adverse effects do not occur to the fetus
(56 µg/L). Even individuals consuming up to 4.5 kg seafood per
week with predicted exposure levels of 9.6 µg/kg bw/wk had
maximum blood MeHg levels of 18 µg/L. When blood levels
were converted to weekly exposure for women of childbearing
age, the data indicated an average exposure of 0.4 ± 0.3 µg/kg
bw/wk, as compared to a predicted average exposure of 1.3 ±
0.9 µg/kg bw/wk based on consumption and contamination data
for the same group of women. Overall, based on the study re-
sults, the authors concluded that the general population should
consume at least 2 servings of ﬁsh, especially oily ﬁsh, per week
and pregnant and nursing women should limit consumption of
predatory ﬁsh to once per week.
Other studies conducted among French consumers have re-
ported that women of childbearing age had a 3% to 5% probability
of exceeding the PTWI for MeHg, based on data from exposure
assessments (Cr´ epet and others 2005; Verger and others 2007). In
order to examine methods for reducing MeHg exposure, Cr´ epet
and others (2005) assessed the probabilistic effects of 5 differ-
ent risk management scenarios (assuming 100% compliance): (1)
no change in consumption patterns, (2) remove all predatory ﬁsh
above1.0ppmMeHgandallotherﬁshabove0.5ppmMeHgfrom
the market, (3) remove all ﬁsh exceeding 0.5 ppm MeHg from the
market, (4) remove 12 species of predatory ﬁsh from the market,
or (5) restrict consumption of predatory ﬁsh to an exact number of
portions per week. Current ﬁsh consumption and exposure levels
c   2012 Institute of Food Technologists® Vol. 11, 2012  Comprehensive Reviews in Food Science and Food Safety 499Risk-beneﬁt analysis of seafood consumption...
were obtained from a previous survey (French INCA survey) that
used a 7-d food log obtained from a nationally representative sam-
ple of the French population. Cr´ epet and others (2005) utilized
data from 1945 male and female adults and 848 children within
this data set, combined with mercury levels reported in previous
studies for 89 individual seafood items. Average consumption of
seafood varied for each age group, with children consuming 174
g/wk and adults consuming 285 g/wk. Mean body weights were
19 kg for children ages 3 to 6 y, 29 kg for children ages 7 to
10 y, and 58 kg for women of childbearing age. Based on these
data, under scenario 1 the probability of exceeding the PTWI for
MeHg was 4.4% for women of childbearing age and 6.7% for chil-
dren (12.6% for ages 3 to 6 y; 5.0% for ages 7 to 10 y). Scenarios 2
and 3 did not signiﬁcantly reduce exposure levels among children,
but scenario 3 (removing all ﬁsh above 0.5 ppm) did signiﬁcantly
reduce probability of MeHg exposure among women of child-
bearing age to 0.6%. In scenario 4, where 12 predatory species
are removed from the market, the authors reported signiﬁcant re-
ductions in MeHg exposure for women of childbearing age (0%
probability of exceeding the PTWI for MeHg) and children ages
3 to 6 y (2.8% probability), but not among children aged 7 to 10
y (1.5% probability). Under scenario 5, the authors suggested an
exact number of portions of predatory ﬁsh per week that would
allow target groups to remain under the PTWI for MeHg. For ex-
ample, a recommendation that women of childbearing age limit
consumption to two, 170-g portions (or 340 g) of predatory ﬁsh
per week or to 255 g per week if also consuming nonpredatory
ﬁsh. Overall, the authors suggested that risk management options
that provide advice on food consumption, such as scenario 5,
are more efﬁcient compared to additional restrictions for MeHg
levels in ﬁsh. However, a later study examining the effects of a
risk-beneﬁt advisory among French consumers reported that the
advisory did not lead to a decrease in predatory ﬁsh consumption,
but it did result in a signiﬁcant decrease in overall ﬁsh consumption
(Verger and others 2007).
A subsequent study compared the exposure levels of PCBs and
dioxins to intake levels of omega-3 fatty acids among 401 French
ﬁsh consumers in western coastal areas (Verger and others 2008).
The consumption data used in this study were obtained previously
in the ﬁsh advisory study, which utilized a 1-mo food diary de-
tailing types and frequency of seafood consumed for 195 men and
206 women (Verger and others 2007). The men had an average
body weight of 75 kg and ate seafood 3.3 times per week, while
the women had an average body weight of 62 kg and ate seafood
2.9 times per week. Exposure levels were calculated using data
from the French Ministry of Agriculture and Fisheries. Overall,
20% to 30% of the target population was estimated to exceed the
PTWI established by the Scientiﬁc Committee on Food (SCF)
for dioxins and dl PCBs of 14 pg TEQ/kg bw/wk. About 25%
of the total exposure was from PCDDs and PCDFs and the re-
maining 75% was from dl PCBs. On the beneﬁt side, about 60%
of the target population obtained the recommended intake of 500
mg/d long-chain omega-3 fatty acids. When risks and beneﬁts
were compared, only 41% of the study participants had an optimal
balance of meeting the RDA of omega-3 fatty acids while remain-
ing below the PTWI for dioxins and dl PCBs: 19% of individuals
met the RDA but exceeded the PTWI, while another 38% of
individuals were below the PTWI but were also below the RDA.
The authors concluded that consuming the RDA for omega-3s
of 500 mg/d through seafood consumption was compatible with
the threshold for dioxins and dl PCBs, but that consumers with
omega-3 intakes above 1500 mg/d from seafood consumption
were likely to also be exceeding the PTWI for dioxins and dl
PCBs.
Pouzaud and others (2009) assessed seafood consumption pat-
terns and intake of MeHg and omega-3 fatty acids among 161
pregnant French women living in a coastal region with high-ﬁsh
consumption. The authors used the food frequency questionnaire
from the CALIPSO study to obtain seafood consumption data for
women at both 12 and 32 wk of pregnancy. Portion sizes were
estimated based on a catalog of photos presented to the study
participant. At both time points, hair samples were obtained for
MeHg testing and body weights were recorded. At week 12, par-
ticipants had a mean seafood consumption of 322 g/wk and an
average body weight of 60 kg, compared to a mean seafood con-
sumption of 309 g/wk and average body weight of 73 kg at week
32. The mean dietary exposure to MeHg from seafood was not
signiﬁcantly different at the 2 time points, with an overall range of
0.6 to 0.7 µg/kg bw/wk. There was also no signiﬁcant difference
in the hair MeHg concentrations across the 2 time points, which
ranged from 0.1 to 3.7 ppm, with a mean of 0.8 ppm. Overall,
about 5% of the women were exceeding the PTWI for MeHg,
similar to results of previous studies on women of childbearing
age (Cr´ epet and others 2005; Verger and others 2007), and about
50% of the women were not obtaining the RDA of 500 mg/d for
long-chain omega-3 PUFAs. The authors used a cluster analysis
tool to group the study participants into 5 different categories re-
lated to ﬁsh consumption and exposure levels, and found that only
women consuming a high proportion of fatty ﬁsh meet the RDA
for omega-3 fatty acids without exceeding the PTWI for MeHg.
Domingo and others (2007a) estimated dietary exposure to
DHA + EPA and chemical contaminants among Spanish con-
sumers. The authors measured fatty acids, metals (Hg, Cd, Pb),
andorganicpollutants(dioxins,dlPCBs,polybrominateddiphenyl
ethers (PBDEs), polychlorinated diphenyl ethers (PCDEs), HCB,
polychlorinated naphthalene (PCNs), and (PAHs) in the edible
portions of the top 14 species consumed in Spain. Daily consump-
tionratesofthese14specieswerecalculatedfora70-kgmalebased
on consumption data obtained previously and a standard meal size
of 227 g. The average EPA + DHA intake was determined to
be 244 mg/d, which is very close to the level recommended
by FAO/WHO (250 mg/d). The estimated intakes of total Hg
(0.14 µg/kg bw/d), Cd (0.02 µg/kg bw/d), and Pb (0.03 µg/kg
bw/d) were all below the provisional tolerable intakes established
bytheFAO/WHOforthesecompounds(Table2).Whenthecor-
rection factor of 0.85 is applied to the total Hg intake, the MeHg
intake can be estimated at 0.12 µg/kg bw/d, which is below the
PTWIbutslightlyabovetheRfDestablishedbytheU.S.EPA.The
estimated intakes of dioxins and dl PCBs (0.54 pg TEQ/kg bw/d)
as well as HCB (0.16 ng/kg bw/d) were all below the PTWIs
established by FAO/WHO for noncarcinogenic effects. The total
intake of 7 carcinogenic PAHs was associated with an increased
cancer risk of 0.27 × 10−6 (that is, 2.7 incidences of cancer per
10000000 people) resulting from chronic exposure over a 70-y life
span, based on EPA CSFs. Tolerable intake limits have not been
established for PBDEs, PCDEs, and PCNs, which had estimated
exposure levels of 0.30, 0.56, and 0.02 ng/kg bw/d, respectively.
The authors did not report the percentage of the target popula-
tion that may be at risk from excess exposure to contaminants or
deﬁcient intake of EPA + DHA. In order to help consumers re-
main below exposure limits for carcinogenic and noncarcinogenic
effects, the authors developed recommended monthly ﬁsh con-
sumption guidelines for the top 14 ﬁsh in Spain. They determined
the greatest noncarcinogenic risk to be from MeHg exposure, and
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recommended limiting consumption of tuna to 2 meals per month
and swordﬁsh to 0.5 meals per month. The greatest carcinogenic
risk was determined to be from PAHs and dioxins. To remain
below PAH exposure limits, recommended consumption levels
were calculated to be between 0.5 (clam/mussel/shrimp) and 4
(hake/redmullet/sole/cuttleﬁsh/squid)mealspermonth,depend-
ing on the species. To remain below dioxin exposure limits recom-
mended consumption levels were calculated to be between 1 (red
mullet) and 16 (hake or cuttleﬁsh) meals per month, depending
on ﬁsh species. However, the authors did not compare the risks of
reducing ﬁsh consumption to these levels in terms of the concomi-
tant decreased intake of EPA + DHA that would occur and the
subsequent increases in risk of cardiovascular disease and mortal-
ity. In a companion paper, Domingo and others (2007b) presented
an interactive risk-beneﬁt online tool that allows the consumer to
input their weight, meal size, and consumption frequency in order
to calculate their intake of EPA + DHA and exposure to metals
and organic pollutants from the 14 seafood types examined above.
A study from The Netherlands reported the development of a
probabilistic model to calculate simultaneous exposure to multiple
compounds from food and to predict different dietary scenarios
(vanderVoetandothers2007).Themodelwasusedtoassesslong-
term intake of EPA + DHA, dioxins, and dl PCBs from a total diet
perspective, as well as predict the effects of replacing other types of
food in the diet with seafood. Dietary patterns were derived from
the Dutch National Food Consumption Survey of 1997/1998,
in which body weight and food intake were recorded for 6250
Dutch individuals using a 2-d food diary that included amount
and frequency of consumption. The authors considered 18 food
types in the model, 11 of which were ﬁsh/shellﬁsh, and combined
levelsofdioxins, dl PCBs,and EPA+DHA inthesefoods with the
dietary information to estimate total intake of these compounds.
In order to compare the FAO/WHO TDI for dioxins and dl PCBs
with the Health Council of The Netherlands adequate intake (AI)
for EPA + DHA (450 mg/d), the AI was expressed in terms of
body weight for a 65-kg individual (7 mg/kg bw/d). Based on 500
random samples from 10000 Monte Carlo simulations, the results
of the dietary analysis showed that in most cases (98% to 99%) the
EPA + DHA intake was below the body weight-adjusted AI and
the dioxin and dl PCB exposure was below the TDI established by
FAO/WHO.Onlyabout2%ofthepopulationwasabovethebody
weight-adjusted AI and below the TDI for dioxins and dl PCBs.
In addition to calculating the percentage of the sample population
that is meeting health-based guidelines, the authors also examined
the probable effects of replacing beef and pork consumption with
salmon, eel, or a mixture of fatty ﬁsh (salmon, eel, herring, and
mackerel) at levels of 10%, 25%, 50%, and 100%. The base rate for
frequency of fatty ﬁsh consumption reported in the food diaries
was 5.3%, compared to 68% for beef, 74% for pork, and 27% for
chicken. Overall, the best scenario in terms of meeting health-
based guidance values was found to be substitution with 10% to
25% salmon or a mix of fatty ﬁsh. At higher percentages (50%
to 100%), there was a lower frequency of maintaining dioxin and
dl PCB levels below the TDI. At 10% replacement with these
ﬁsh categories, about 50% of the population reached the AI for
EPA +DHA and only 1.3% of the population exceeded the dioxin
and dl PCB limit, whereas at 25% replacement, more than 90%
of the sample population was able to reach the AI for EPA +
DHA, while less than 5% were predicted to exceed the limits
for dioxins and dl PCBs. On the other hand, substitution of beef
and pork with 25% eel was predicted to result in about 99% of
the population reaching the AI, but also about 11% would be
exceeding the TDI for dioxins and dl PCBs. The authors pointed
out that this analysis was meant to illustrate the use of the statistical
model, and that a more complete analysis should be carried out
that considers uncertainties, alternative data sets, and additional
dietary scenarios. The use of a total diet model, as presented
here, allows for a better overall picture of the dietary intake of
certain compounds and food replacement scenarios may be useful
in developing risk management and communication strategies.
Risk-beneﬁt assessment in Belgium was carried out by Sioen
and others (2008) using a probabilistic model to assess simultane-
ous exposure to PBDEs and omega-3 fatty acids exclusively due
to ﬁsh consumption. Consumption data for some 800 Belgian ﬁsh
consumers representative of the Belgian adult population with re-
spect to age and region was obtained from a SEAFOODplus food
frequency questionnaire in 2004 and body weights were incorpo-
rated based on previously determined age and sex distributions for
the Belgian population. These individuals consumed an average
of 216 ± 204 g seafood per week, as compared to the general
Belgian population, which consumes an average of 168 g/wk.
Based on a 100 to 150 g serving size, these levels are similar to the
recommendations of the Belgian Health Council to consume ﬁsh
1 to 2 times per week. Levels of EPA + DHA and PBDEs were
obtained for 10 ﬁsh commonly available on the Belgian market
(for example, cod, salmon, tuna, saithe, and sole) using previously
published data and exposure levels for 4 different dietary scenarios
were calculated: (1) base consumption (216 g/wk of a variety of
10 ﬁsh), (2) consumption of 150 g/wk of cod (lean ﬁsh) and 150
g/wk of salmon (fatty ﬁsh), (3) consumption of 300 g/wk salmon,
and (4) consumption of 150 g/wk salmon and 150 g/wk herring
(also a fatty ﬁsh). Monte Carlo simulations were used to esti-
mate the variability of the intakes in terms of consumption, body
weight, and concentration of the contaminants and nutrients in
ﬁsh. EPA + DHA intake was adjusted for body weight and was
compared to a health-based guidance value of 9.7 mg/kg bw/d
(derived from a dietary reference intake of 681 mg/d for a 70-kg
individual consuming 2046 kcal/d). The results of the analysis re-
vealed that scenario 1 was associated with the lowest mean intakes
of both EPA + DHA (3.54 mg/kg bw/d) and PBDEs (0.85 ng/kg
bw/d), while consumption of 2 servings per week of salmon in
scenario 3 allowed for the highest ratio of EPA + DHA (11.9
mg/kg bw/d) to PBDEs (1.28 ng/kg bw/d). The replacement
of 1 serving of salmon with herring in scenario 4 also provided
elevated levels of EPA + DHA (9.6 mg/kg bw/d) compared to
scenarios 1 and 2, but led to slightly higher intake of PBDE
(2.4 ng/kg bw/d). While there is no established tolerable intake
for PBDEs, the lowest observed adverse effect level associated with
this group of compounds has been reported to be 0.6 mg/kg bw
for the penta-BDEs (Darnerud 2003; Siddiqi and others 2003).
Overall, increased ﬁsh consumption was associated with increased
intake of EPA + DHA and PBDEs, with the greatest beneﬁt: risk
ratio being from consumption of 2 servings of salmon per week.
In a subsequent study, Sioen and others (2009) used the prob-
abilistic approach described above to assess exposure to several
nutrients (EPA + DHA, vitamin D, iodine) and contaminants
(MeHg, iPCBs, dioxins + dl PCBs) on a global scale. The authors
used consumption data for 7 different seafood categories gathered
by the Global Environment Monitoring System (WHO 2007),
which reports average food consumption for 13 regional "cluster"
diets representing 183 countries worldwide. General levels of nu-
trients and contaminants were obtained from databases developed
in previous studies (Sioen and others 2007a, b) and an intake as-
sessment was performed for all 13 cluster diets with probability
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distributions ﬁtted for each seafood category, nutrient, and con-
taminant. Exposure levels were based on the general adult popula-
tion, with a mean body weight of 60 kg for most regions and
55 kg for individuals from Asian countries. The highest
seafood intake was reported for Cluster L, which included
Japan, Korea, Philippines, Madagascar, and others, with 69.0
g/person/d, followed by Cluster F (the Nordic-Baltic countries;
49.2g/person/d),andClusterG(Afghanistan,China,India,Thai-
land, and others; 45.0 g/person/d). The 2 clusters with the highest
seafood intake had the highest intakes of EPA + DHA (400 to 600
mg/person/d), iodine (30 to 40 µg/person/d), and vitamin D (3
to 4 µg/person/d). Differences in the dietary patterns between
regions were reﬂected in the types of contaminants present: Clus-
ters L and F consume relatively high levels of pelagic ﬁsh and had
the highest exposure to MeHg (about 200 to 300 ng/kg bw/d),
whereas Cluster G, which consumed a greater proportion of fresh-
water ﬁsh, cephalopods, crustaceans, and mollusks, had lower ex-
posuretoMeHg(about100ng/kgbw/d)butthehighestexposure
to iPCBs (about 60 ng/kg bw/d) and dioxins + dl PCBs (about
3.3 pg TEQ/kg bw/d). In order to combine data for nutrients
and contaminants, the intake of EPA + DHA was divided by the
dietary reference intake (DRI) of 500 mg/d and graphed against
the exposure to either MeHg or dioxins + dl PCBs divided by the
TDIs established by the JECFA. These plots revealed that most
clusters were not exposed to contaminants above the tolerable ex-
posure levels; however, they also were not obtaining sufﬁcient EPA
+ DHA to meet the DRI, with intake levels of about 100 to 300
mg/d. The only cluster diet (Cluster L) that obtained 500 mg/d of
EPA + DHA also exceeded the TDIs for MeHg and dioxins + dl
PCBs. Cluster G exceeded the TDI for dioxins + dl PCBs and had
a daily EPA + DHA intake of about 200 to 300 mg, while cluster F
wasjustbelowtheDRIforEPA+DHAandhadexposureatlevels
around the TDIs for both MeHg and dioxins + dl PCBs. When
the authors compared the mean exposure levels for each cluster to
the tolerable intakes for MeHg and dioxins + dl PCBs established
by the Scientiﬁc Advisory Committee on Nutrition/Committee
on Toxicity out of the United Kingdom (SACN/COT) to protect
against nondevelopmental health problems (Table 2), none of the
clusters exceeded the guidance values. There are several uncertain-
ties of this study that could inﬂuence the estimated nutrient and
contaminant exposure levels. For example, food consumption data
were gathered by dividing food availability for a given country by
the total population and it tends to overestimate consumption by
about 15%. Also, the nutrient and contaminant data were based on
seafood tested in Europe or North America and do not represent
regional seafood consumed by some cluster diets. In conclusion,
the authors noted that the beneﬁts outweigh the risks of seafood
consumption when the focus is on nondevelopmental effects and
they called for a more in-depth international study that would
include local nutrient and contaminant concentration data.
Cardoso and others (2010) examined seafood consumption pat-
ternsacross8Europeancountries(Germany,France,UnitedKing-
dom, Italy, Spain, The Netherlands, Portugal, and Iceland) and
calculated the probability of exceeding the tolerable intake for
MeHg or being deﬁcient in EPA + DHA for consumers in each
country. The authors took into account the 5 most-consumed
types of seafood for each country and calculated per capita weekly
consumption, assuming that two-thirds of the seafood weight was
edible and average body weight was 60 kg. Because detailed con-
sumption surveys were not used, log-normal distributions were
constructed to reﬂect seafood consumption patterns among dif-
ferent consumers, including individuals that do not regularly eat
seafood, and the values of each distribution curve were randomly
sampled using a sample size of 10000 with the Monte Carlo
method. As was the case with Sioen and others (2009), the nu-
trient and contaminant data were not representative of the entire
study population, but rather were based on seafood collected in
Portugal. The probabilities of exceeding the weekly reference in-
takes for MeHg and EPA + DHA from consumption of each
seafood species were calculated using a tail-estimation estimator
for most cases and a plug-in estimator for the few cases with
high probabilities. Total per capita seafood consumption for the
8 countries ranged from 140 g/wk in the United Kingdom to
630 g/wk in Iceland, while consumption of the top 5 species
examined in this study for each country ranged from 80 g/wk
in the United Kingdom to 390 g/wk in Iceland. Based on total
seafood consumption, the probability of exceeding 500 mg/d of
EPA + DHA was estimated at 0.3% for the United Kingdom,
2.0% for Italy, 12.4% for Germany and The Netherlands, 20.3%
to 24.2% for France and Iceland, 61.1% for Spain, and 66.0% for
Portugal. Although Spain and Portugal consume less per capita
seafood (210 and 290 g/wk, respectively) than Iceland, these 2
countries include sardines among the top 5 species, which are a
rich source of EPA + DHA. The probability of exceeding the
PTWI established by JECFA for MeHg based on total seafood
consumption was below 5% for most countries and reached 6.7%
for Portugal and 9.6% for Iceland. Among the top 5 ﬁsh consumed
in Iceland, the highest probabilities of exceeding the PTWI for
MeHg based on a single ﬁsh species were with tuna (0.50%) and
haddock (0.34%), which had consumption levels of 69 and 158
g/person/wk, respectively. However, exceeding the PTWI based
on exclusive consumption of either of these ﬁsh would require
about ﬁve 100-g servings of tuna per week (7 times the current
consumption levels) or fourteen 100-g servings of haddock (9.2
times the current consumption levels). The results of this study
highlight the fact that selecting ﬁsh high in EPA + DHA and low
in MeHg will improve the beneﬁt:risk ratio related to seafood
consumption.
Assessments using combined risk-beneﬁt dose-response
models. In 2009, the U.S. FDA issued 2 draft reports examining
the health outcomes of seafood consumption with the purpose
of providing additional scientiﬁc information to help address con-
cerns over risks and beneﬁts of commercial seafood in the United
States (FDA 2009a, b). In one report, the beneﬁcial effects of
seafood consumption and omega-3 fatty acids for certain neu-
rodevelopmental and cardiovascular endpoints were summarized
(FDA 2009b) and in the other report, a quantitative risk-beneﬁt
assessment was conducted for seafood consumption (FDA 2009a).
The risk-beneﬁt assessment was focused on 3 health endpoints:
(1) fetal neurodevelopment, (2) risk of fatal CHD, and (3) risk of
fatal stroke. The consideration of both the beneﬁts and the risks
of seafood in the same quantitative analysis was a novel approach
for the FDA, which has historically focused on quantifying the
risk but not the countervailing beneﬁts of a particular food. Cur-
rent levels of U.S. ﬁsh consumption (that is, amounts and species)
were estimated based on 3 sources of data: a 3-d food survey
conducted by the U.S. Department of Agriculture between 1989
and 1991 (USDA 1993), the 30-d National Health and Nutri-
tion Examination Survey (NHANES) conducted in 2001 to 2002
(CDC 2004), and market share data on consumable commercial
ﬁsh in 2005 from the National Marine Fisheries Service (NMFS).
This information was combined with MeHg concentrations in
different ﬁsh species, as reported by FDA, EPA, and NMFS, to
calculate current levels of MeHg exposure from ﬁsh consumption.
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The negative effects of MeHg on fetal neurodevelopment were
modeled based on verbal development measurements primarily in
children from the Iraq MeHg wheat poisoning event (Marsh and
others 1987), with some data from the Seychelles Islands study
(Myers and others 1995), while dose-response relationships re-
garding the positive effects of ﬁsh consumption were modeled
using data from the UK cognitive development study (Daniels
and others 2004). The effects of prenatal MeHg exposure and ﬁsh
consumption were combined to estimate a net effect of IQ size
equivalents in offspring using several hypothetical dietary scenar-
ios involving women of childbearing age (15 to 45 y). IQ size
equivalents are IQ points based on Z-Score conversions, which
are statistical tools that measure the size of an effect and facilitate
the comparison of results from different models. At current con-
sumption levels (about 5% of women eating ≥340 g of ﬁsh/week,
95% of women eating <340 g/wk), there is an estimated net neu-
rodevelopmental beneﬁt equivalent to 0.225 IQ point per child,
with 99% of the population likely to have a net beneﬁt on IQ size
equivalents (in excess of 1 IQ point per child for about 5% of pop-
ulation), 0.9% of the population likely to have no net effect, and
0.1% of the population likely to experience a net negative effect,
equivalent to about 0.04 IQ point. In a scenario where women
do not change their current consumption amounts, but instead
eat only ﬁsh low in MeHg (≤0.12 ppm), an increase equivalent
to 0.02 IQ point was predicted. Another scenario in which 100%
of women were eating exactly 340 g of ﬁsh per week resulted in
a net beneﬁt equivalent to 0.57 IQ point. On the other hand,
if women that are currently eating more than 340 g/wk were to
decrease their consumption to this level, a net decrease equivalent
to IQ point of 0.01 was predicted. Overall, these results indicate
the greatest net neurodevelopmental beneﬁt for pregnant women
with increased ﬁsh consumption, especially ﬁsh that are low in
MeHg.
Cardiovascular effects in the FDA risk-beneﬁt assessment (FDA
2009a) were assessed using 2 types of models (meta-analysis and
pooled analysis) that were developed based on studies that re-
ported the effects of ﬁsh consumption, but not omega-3 fatty
acids or MeHg, on CHD or stroke fatalities. The CHD meta-
analysis model was based on the meta-analysis conducted by He
and others (2004b), while the CHD-pooled analysis model in-
cluded the studies in this meta-analysis as well as 3 additional
studies published later (Folsom and Demissie 2004; Nakamura
and others 2005; Iso and others 2006). The stroke meta-analysis
model was based on another meta-analysis conducted by Bouzan
and others (2005). The stroke-pooled analysis model utilized this
meta-analysis as well as studies by Mozaffarian and others (2005),
Nakamura and others (2005), and 3 additional studies that were
analyzed by He and others (2004a). Based on the central estimates
of these models, current levels of ﬁsh consumption were esti-
mated to be averting approximately 31000 (meta-analysis model)
to 40000 (pooled analysis model) deaths per year from CHD and
approximately 22000 (meta-analysis) to 25000 (pooled analysis)
deaths per year from stroke. Results of dietary scenarios suggested
that if all women of childbearing age ate 340 g of ﬁsh per week,
there would be a predicted decrease of approximately 250 (meta-
analyses) to 340 (pooled analyses) deaths per year from CHD and
stroke. If there were a 10% decrease in the amount of ﬁsh con-
sumed by adult men and older women (> 46 y), there would be
a predicted increase of approximately 3500 (pooled analyses) to
4000 (meta-analyses) deaths per year from CHD and stroke; and if
all adult men and women were to increase their ﬁsh consumption
by 50%, there would be a predicted decrease of approximately
11000 (pooled analyses) to 18000 (meta-analyses) deaths per year
from CHD and stroke. However, it should be noted that the con-
ﬁdence intervals for the pooled analyses models are, by design,
wider than those of the meta-analyses models and therefore they
did include a small possibility that current ﬁsh consumption is
associated with deaths in each age/gender category. Nevertheless,
the bulk of the probability distribution did indicate a beneﬁcial
effect of ﬁsh consumption, making it more likely than not that
increased ﬁsh consumption leads to a decrease in cardiovascular
mortality.
The approach of combining the risks and beneﬁts into a net
health effect for a given endpoint was also used in a study exam-
ining potential development of species-speciﬁc ﬁsh consumption
advice (Ginsberg and Toal 2009). The concentrations of MeHg
and omega-3 fatty acids in 16 species of ﬁsh commonly available
in the state of Connecticut, U.S.A, were used to predict the de-
velopmental and cardiovascular health effects associated with each
ﬁsh. The cardiovascular dose-response relationship was developed
based on the results of Guallar and others (2002), who found that
the relative risk for a 1st myocardial infarction increased by 23%
per 1 ppm hair mercury and on the ﬁndings of Mozaffarian and
Rimm (2006), which showed that increasing EPA + DHA in-
take from 100 to 250 mg/d was associated with a 14.6% decrease
in the risk of CHD death. Although these endpoints are a mea-
sure of cardiovascular health and they were compared equally in
this risk-beneﬁt assessment, CHD mortality includes sudden death
and death from myocardial infarction, whereas a ﬁrst myocardial
infarction is not necessarily fatal. The dose-response relationship
for neurodevelopmental health was based on the study of Oken
and others (2005), who reported a 2.0-point increase in infant
visual recognition memory (VRM) score per 100 mg ﬁsh oil/d
and a 7.5-point decrease in VRM score per 1 ppm hair mercury.
However, it should be noted that Oken and others (2005) only
observed adverse effects among participants that had hair mercury
levels above 1.2 ppm, and the maximum level of hair mercury
reported was 2.4 ppm. Interestingly, Ginsberg and Toal (2009) in-
corporated a threshold of 0.51 ppm hair mercury into the cardio-
vascular dose-response model as the level below which no adverse
effects were evident, but the hair mercury threshold for adverse
cognitive effects observed by Oken and others (2005) was not
incorporated into the neurodevelopmental dose-response model.
The level of mercury exposure resulting from consumption of
one 170-g meal was calculated for each ﬁsh species and then con-
verted to hair mercury concentration using a one-compartment
model (Rice and others 2003). The results showed that when one
to two, 170-g meals per week are consumed, the estimated car-
diovascular beneﬁts from omega-3 fatty acids outweigh the risks
from MeHg for all species except shark, swordﬁsh, and yellowﬁn
tuna. On the other hand, one 170-g meal per week from 9 out
of the 16 ﬁsh examined was predicted to result in adverse neu-
rodevelopmental effects, even for some low-mercury ﬁsh like cod
(0.11 ppm) and canned light tuna (0.12 ppm). This is likely due
to the relatively low levels of omega-3 fatty acids in these ﬁsh and
the fact that the hair mercury threshold level for adverse cogni-
tive effects was not incorporated into the model. Consumption
of these 9 ﬁsh at this level would not be expected to exceed the
RfD established by EPA. As expected, low-mercury ﬁsh with high
levels of omega-3 fatty acids, such as salmon, trout, and herring,
exhibited the greatest net beneﬁts to neurodevelopment. The au-
thors used the results of the risk-beneﬁt assessments and acceptable
body burdens based on the RfD to suggest species-speciﬁc ﬁsh
consumption advisories. For example, for individuals concerned
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with neurodevelopmental effects, the authors recommended un-
limited consumption (up to one, 170-g meal per day) for 7 of
the ﬁsh species; limited consumption of canned light tuna and
cod (two, 170-g meals per week), limited consumption of 4 other
species (that is, canned white tuna, tuna steak, halibut, sea bass, and
lobster) to just one, 170-g meal per week, and complete avoidance
of shark and swordﬁsh. However, the authors note that the focus
of this study was to present a framework for risk-beneﬁt assessment
and the uncertainties in the dose-response relationships presented
here make the conclusions tentative.
Assessments based on composite metrics
Composite metrics allow for the integration of risks and bene-
ﬁts for multiple health endpoints into a single net health impact.
These assessments can combine 2 or more types of common met-
rics, such as mortality, morbidity, or disease incidence, to quantify
the cumulative effect on health. Most studies assessing the risks
and beneﬁts of seafood with composite metrics have utilized the
QALYs to express the net health outcome (Ponce and others 2000;
Cohen and others 2005a; Guevel and others 2008), and 1 study
used a monetary value based on standard EPA health beneﬁt trans-
fer ﬁgures (Shimshack and Ward 2010). These studies are reviewed
here.
Studies using QALYs. The earliest publication that applied
QALYs to risk-beneﬁt assessment of seafood was presented by
Ponce and others (2000). Beneﬁts of ﬁsh consumption were de-
ﬁned as a decrease in myocardial infarction mortality and the risks
were deﬁned as neurodevelopmental delays associated with prena-
tal MeHg exposure. The beneﬁt to dose-response relationship for
ﬁsh consumption was modeled by logistic regression from sum-
mary epidemiological data collected for an adult male population
in Chicago, IL (U.S.A.), over a 30-y period, which found an in-
verse relationship between ﬁsh consumption and the risk of death
fromCHD,especiallynonsuddendeathfrommyocardialinfarction
(MI) (Daviglus and others 1997). A Weibul excess risk model was
used to develop a dose-response relationship for risks using data on
delayed talking incidence among children in Iraq with gestational
exposure to contaminated grain (Marsh and others 1987). Fish
consumption was examined over a range of intakes (0 to 300 g/d)
and at a range of mercury concentrations (0.5 to 2.0 ppm). The
net health impact of ﬁsh consumption was then calculated for
2 different population groups (n = 100000 individuals/
population): (1) all members of a population and (2) women of
childbearing age (deﬁned by Ponce and others (2000) as 15 to 44
y) and their offspring. When myocardial infarction mortality was
assumed to be equal in severity to delayed talking (that is, starting
to talk at 24 mo of age), the net effect of consumption of two,
100-g servings of ﬁsh per week with mercury levels of 0.5 to 2.0
ppm was predicted to be positive for the total population (2000
to 5000 QALYs), but negative for the subpopulation of women of
childbearing age and their offspring (−250 to 2000 QALYs). The
maximum beneﬁts occurred among the total population when
more than ten, 100-g servings of ﬁsh with 0.5 ppm mercury were
consumed per week, with a net gain of about 15000 QALYs. On
the other hand, the subpopulation of women and children ex-
hibited a net loss of 250 to 2000 QALYs for 2 servings of ﬁsh
per week. When myocardial infarction mortality was weighted as
more severe than delayed talking, two, 100-g servings of ﬁsh per
week were linked to a net beneﬁt of about 5000 QALYs for the
total population, regardless of the mercury concentration in the
ﬁsh (0.5 to 2.0 ppm). The results of unequal weighting were re-
ported to continue to result in a net negative health impact for
the subpopulation of women and children (QALYs not reported).
However, the beneﬁts of ﬁsh consumption to neurodevelopment,
which would be expected to greatly improve the net health im-
pact, were not considered in this model. Further, the mercury
levels for ﬁsh used in this model were higher than those in most
commonly consumed ﬁsh, which generally have concentrations of
<0.05 to 0.35 ppm, with the exception of a few large predatory
ﬁsh, such as swordﬁsh, shark, and king mackerel (FDA 2009c).
To improve future analyses, the authors suggested the inclusion
of a greater number of health endpoints and scenarios comparing
ﬁsh-based diets with other types of diets, as well as the substitution
of ﬁsh with low MeHg levels.
To this regard, a comprehensive risk-beneﬁt assessment was car-
ried out for a range of ﬁsh consumption scenarios using com-
posite metrics that incorporated dose-response relationships from
4 different studies (Cohen and others 2005a). An expert panel
convened by the Harvard Center for Risk Analysis published a
series of 4 papers developing dose-response relationships for ﬁsh
consumption and CHD mortality (K¨ onig and others 2005); ﬁsh
consumption and stroke (Bouzan and others 2005); prenatal DHA
intake and cognitive development (Cohen and others 2005b); and
prenatal MeHg exposure and cognitive development (Cohen and
others 2005c). The dose-response relationships were only devel-
oped for health endpoints that were expected to be substantially
affected by changes in ﬁsh consumption and for which there were
sufﬁcient data for a quantitative analysis. In the study determining
a relationship between ﬁsh consumption and heart disease mor-
tality, including CHD and nonfatal MI, the authors identiﬁed 7
observational studies (Kromhout and others 1985; Ascherio and
others 1995; Daviglus and others 1997; Albert and others 1998;
Oomen and others 2000; Hu and others 2002; Mozaffarian and
others 2002) of individuals with no pre-existing CHD for use in
the dose-response analysis (K¨ onig and others 2005). To develop a
dose-response relationship between ﬁsh consumption and stroke
risk, the authors combined relative risk results from 6 studies (5
prospective cohort studies and 1 case-controlled study) (Gillum
and others 1996; Orencia and others 1996; Iso and others 2001;
Caicoya 2002; He and others 2002; Bouzan and others 2005).
The dose-response relationship between prenatal intake of n-3
PUFAs and cognitive development utilized 8 randomized con-
trol trials (RCTs) (Agostoni and others 1997; Willatts and others
1998; Lucas and others 1999; Birch and others 2000; Makrides
and others 2000; Auestad and others 2001, 2003; Helland and
others 2003) comparing cognitive development for children or
mothers receiving n-3 PUFA supplementation (Cohen and others
2005b). The dose-response relationship between prenatal MeHg
and cognitive effects was determined by aggregating results from
3 major epidemiology studies conducted in the Faroe Islands,
Seychelles Islands, and New Zealand (Cohen and others 2005c).
The dose-response relationships developed in these studies were
then used to calculate the net public health impact of ﬁsh con-
sumption patterns related to risk-beneﬁt advisories. The impacts
of changes in ﬁsh consumption on MeHg exposure, omega-3
fatty acid intake, and servings of ﬁsh per week were estimated
using a modiﬁed version of a previously developed exposure as-
sessment model (Carrington and Bolger 2002; Carrington and
others 2004). This model assumes that 10% to 20% of the popula-
tion does not eat ﬁsh, and therefore health impacts due to changes
in ﬁsh consumption are assumed to affect 85% of the population.
Consumption rates for 42 types of ﬁsh were estimated using data
from the USDA Continuing Survey of Food Intake by Individuals
(CSFII) (USDA 1998) and NHANES data from 1999 to 2000
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(CDC 2003). Levels of MeHg in ﬁsh were obtained from the
FDA and NMFS and levels of omega-3 fatty acids were derived
fromtheUSDAAgriculturalResearchServiceNutrientDataLab-
oratory (http://www.nal.usda.gov/fnic/foodcomp/search/). The
average maternal body weight was estimated at 60 kg and the
baseline ﬁsh consumption was 18.7 g/d (130 g/wk) for women of
childbearing age (15 to 44 y) and 23.1 g/d (160 g/wk) for other
population members ≥15 y of age. The public health impacts of 5
dietary scenarios were compared to the baseline ﬁsh consumption
for the U.S. population: (1) women of childbearing age maintain
current amounts of ﬁsh consumption, but only eat ﬁsh with mer-
cury levels ≤ 0.13 ppm, (2) women of childbearing age decrease
total ﬁsh consumption by 17%, regardless of mercury content, (3)
in addition to women of childbearing age, other members of the
population also reduce ﬁsh consumption by 17%, (4) all females
not of childbearing age and all males increase ﬁsh consumption
by 50%, and (5) all adult females (including those of childbearing
age) and males increase ﬁsh consumption by 50%. When women
of childbearing age maintained current consumption levels but
only ate ﬁsh lower in mercury (scenario 1), a net beneﬁt of 49000
QALYs per year was predicted for the total population, primarily
due to the cognitive beneﬁts of DHA, which would contribute an
average of 0.1 IQ point per child born. Scenario 2 was based on
a study that reported a 17% decrease in overall ﬁsh consumption
by pregnant women following the 2001 FDA advisory (Oken and
others 2003). This dietary scenario was associated with a substan-
tially smaller net beneﬁt to health as compared with scenario 1,
with + 0.02 IQ point per child and a net impact of 9700 QALYs
per year. In scenario 3, where all members of the population de-
creaseﬁshconsumptionby17%,thenethealthimpactwasnegative
(−41000 QALYs per year), with the greatest losses experienced
by elderly males (ages 75 to 84), whose annual CHD mortality
risk would be increased by about 2 in 10000. On the other hand,
the greatest net beneﬁt to health (+120000 QALYs per year) oc-
curred in scenario 4 when ﬁsh consumption was increased by 50%
among all females not of childbearing age and all males, with a
reduced risk for CHD mortality of 5 in 10000 among elderly
men. In the case where all adult males and females increased ﬁsh
consumption by 50%, the total beneﬁts were offset slightly by the
negative impact from MeHg on cognitive development (−0.07
IQ point/child), with a net health impact of +90000 QALYs per
year. The effects of POPs were not considered in this risk-beneﬁt
assessment because they were not expected to be major contribu-
tors to the net health impact; for example, a sample calculation for
scenario 4 based on the data reported by Hites and others (2004a)
showed that exposure to organic contaminants was associated with
a loss of about 600 QALYs per year, compared to the net beneﬁts
of 120000 QALYs per year. The overall results of this risk-beneﬁt
assessment suggest the importance of ﬁsh consumption in terms
of the net health impact for the total population. When compar-
ing the predicted results of scenarios 1 and 2, the importance of
correctly following advisories for women of childbearing age to
consume low-mercury ﬁsh, but not reduce total ﬁsh consump-
tion is also apparent. The results of scenario 3, where the total
population reduces ﬁsh consumption, indicate the potential for
substantial reductions in public health and increased risks of CHD
mortality when advisories targeted at a speciﬁc population inad-
vertently discourage ﬁsh consumption among other population
groups.
Guevelandothers(2008) utilized aQALY approach toassessthe
risks and beneﬁts of high ﬁsh consumers in France. Consumption
data for individuals consuming 2 or more servings of seafood per
week were obtained from the CALIPSO study (Leblanc and others
2006; Bemrah-Aouachria and others 2008) and the most common
types of ﬁsh and seafood were sampled locally and analyzed for
fatty acids and MeHg. This information was combined to deter-
mine the exposure levels for these compounds among the target
populations and then to compare risks and beneﬁts for consumers
with medium and high EPA + DHA intake. Consumers in the
1st quintile of the CALIPSO study (medium EPA + DHA intake)
had an average ﬁsh consumption of 334 g/wk, an average EPA
+ DHA intake of 391 mg/d, and an estimated MeHg exposure
of 0.8 µg/kg bw/wk. On the other hand, consumers in the 5th
quintile (high EPA + DHA intake) consumed an average of 1104
g seafood/wk, with a daily EPA + DHA intake of 2700 mg and a
weekly MeHg exposure of 2.6 µg/kg bw. The net QALYs associ-
atedwithincreasingEPA+DHAintakefrommediumtohighlev-
els were calculated for the adult population in France using dose-
response curves developed previously linking ﬁsh consumption to
cognitive and cardiovascular endpoints (Bouzan and others 2005;
Cohen and others 2005a, b, c; K¨ onig and others 2005). Additional
dose-response curves linking EPA + DHA intake to the same car-
diovascular endpoints were also developed by the authors based on
previous studies (Dolecek and Grandits 1991; Iso and others 2001;
He and others 2002; Hu and others 2002; Mozaffarian and others
2002).ThenetresultofincreasingEPA+DHAintakefrom391to
2700 mg/d was beneﬁcial for both cognitive (+5949 QALYs) and
cardiovascular endpoints (91229 to 114475 QALYs), regardless of
the dose-response model. When all endpoints were combined, the
total QALYs associated with increasing ﬁsh-derived EPA + DHA
intake were 97248 using the EPA + DHA loglinear model devel-
oped by Guevel and others (2008); 116800 using the ﬁsh linear
model from the Harvard Center for Risk Analysis (Cohen and
others 2005a); and 285774 using the EPA + DHA exponential
model developed by Guevel and others (2008). Despite the net
beneﬁts associated with increasing ﬁsh consumption and EPA +
DHA intake, the potential effects of MeHg on neurodevelopment
resultedinanegativelowerboundofthe95%conﬁdenceintervals,
ranging from −104380 QALYs for the EPA + DHA exponential
model to −278665 for the EPA + DHA loglinear model. Overall,
these results were in agreement with Cohen and others (2005a)
that the beneﬁts of ﬁsh consumption outweigh the risks; however,
the magnitude of these effects is inﬂuenced by the type of dose-
response curve utilized. Integration of additional risks and beneﬁts
into the QALY model was recommended for future studies on this
topic.
Health-based monetary impacts. The use of monetary val-
ues to quantify risks and beneﬁts of seafood consumption was
explored in a study that considered the effects of mercury advi-
sories on dietary patterns (Shimshack and Ward 2010). The dietary
changes following the 2001 U.S. FDA advisory on mercury in
seafood were examined using household-level seafood consump-
tion data obtained from the Information Resources, Inc.’s InfoS-
can Consumer Network database. The data used by Shimshack
and Ward were collected from close to 15000 consumers that
were asked to scan the universal product codes for all prod-
ucts purchased from all stores upon returning home over a 3-y
period (2000 to 2002). Changes in seafood types and amounts
were investigated following the 2001 advisory for “at-risk” house-
holds with pregnant women, nursing women, or children under
6. Similar to the results reported by Oken and others (2003), a
17% decrease in ﬁsh consumption by pregnant women was ob-
served following this advisory (Shimshack and Ward 2010). Of
those who decreased their ﬁsh consumption, “at-risk” households
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decreased ﬁsh consumption 21.4% and there was a 60% increase
in the number of consumers with no signiﬁcant ﬁsh and shell-
ﬁsh consumption. Overall, there was no evidence of differen-
tial avoidance of high mercury ﬁsh, with at-risk groups reducing
consumption of low-mercury seafood like salmon (27.9% reduc-
tion) and shrimp (17.5% reduction). Consumption of white tuna
and light tuna fell by 14.0% and 19.5%, respectively. However,
when education level was considered, households with a college
degree did show selective avoidance of high-mercury ﬁsh, with
an overall decrease in MeHg exposure of 27.9% (compared to
0.003% for less educated households), but there was also a sub-
stantial decrease of about 20% in the n-3 fatty acid intake among
both education groups. The health impacts of these declines in
seafood consumption were calculated using the cognitive and car-
diovascular dose-response models developed previously (Bouzan
and others 2005; Cohen and others 2005a, b, c; K¨ onig and oth-
ers 2005). However, rather than using a QALY approach, the net
health impacts were expressed in terms of monetary values us-
ing U.S. EPA beneﬁt transfer ﬁgures of $13084 per IQ point and
$7.52 million for the value of statistical life, based on 2007 U.S.
dollaramounts.Overall,the21.4%reductioninseafoodconsump-
tion following the 2001 U.S. FDA advisory was estimated to have a
net health impact of U.S. −$30. Declines in MeHg exposure were
associated with a beneﬁt of +0.012 IQ points/child, while de-
clines in the EPA + DHA intake were associated with −0.008 IQ
points/child, resulting in a net beneﬁt of 0.004 IQ points/child
following the advisory (equivalent to U.S. $61). On the other
hand, the decline in EPA + DHA intake was also associated with
a net increase in CHD and stroke mortality of +0.63 deaths per
100000 adults (equivalent to U.S. −$91). The effects of an ide-
alized scenario presented by Cohen and others (2005a; scenario
1), in which at-risk households maintain overall ﬁsh consumption
amounts but only eat low-mercury ﬁsh, were also examined by
Shimshack and Ward (2010) in terms of risks and beneﬁts to neu-
rodevelopment. This scenario resulted in a net beneﬁt of 0.039
IQ points/child (U.S. $587). These results indicate the importance
of targeted strategies for reducing MeHg exposure without con-
comitantly reducing n-3 fatty acid intake in order to receive the
greatest health beneﬁts from seafood.
Conclusions
While the application of risk-beneﬁt analysis to speciﬁc foods
is a relatively new ﬁeld of study, it represents a powerful tool that
allows decision makers to set policy that can have a universal bene-
ﬁcial effect. Although science-based, risk-beneﬁt analysis remains
complexbutwillcontinually improvewithincreasedanalyses,new
methodologies, and larger studies. It also provides new research
opportunities for investigating the multiple components of food as
well as their physiological and nutritional interactions in popula-
tions. There are continuing efforts to maximize beneﬁts and min-
imize risks through optimization of food consumption patterns.
Consumers are informed about what foods to avoid, while being
encouraged to consume others that will, hopefully, promote bet-
ter health. Seafood is somewhat unique as few other foods present
so many deleterious and beneﬁcial components in one packet.
Many of the studies highlighted in this review show the impor-
tance of maximizing the beneﬁt: risk ratio by consuming ﬁsh that
are high in EPA + DHA but low in contaminants. Although the
beneﬁts of EPA + DHA consumption can be negated by exces-
sive consumption of high-MeHg seafood by sensitive populations,
such as pregnant women and young children, under-consumption
of EPA + DHA across both the at-risk and general population
groups is of equal concern. Studies also demonstrate that attempts
to “protect” an at-risk population can have negative unintended
consequences on that group and on the much larger overall pop-
ulation. It is therefore prudent that agencies consider the impact
of unintended consequences that messaging can create. Regard-
less of the risk-beneﬁt method utilized, this review indicates that
results from studies overwhelmingly support the idea that mes-
saging regarding seafood consumption risks requires a targeted
strategy that does not discount the beneﬁts. Sensitive populations
will likely beneﬁt by following risk advisories and reducing con-
sumption of high-mercury ﬁsh; however, there is a need to be
careful about how these advisories are worded and released to
the public. Studies have shown that messaging reduces ﬁsh con-
sumption in general, in both the target and nontarget populations,
resulting in an overall reduction in the potential health beneﬁts
derived from EPA + DHA. This is a cause for concern as most
populations are not currently meeting the recommended intake
levels for EPA + DHA. While a majority of research has shown
that seafood consumption greatly outweighs the risks, it is im-
portant to keep in mind that this ﬁeld of science is just at the
incipient stages of determining how to accurately assess the every-
day choices we make in our diet and how these ultimately affect
our lives.
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c
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c
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c
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c
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ﬁ
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ﬁ
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c
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c
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i
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c
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c
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b
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i
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c
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c
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c
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c
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c
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c
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c
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c
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p
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c
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b
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c
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c
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r
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e
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c
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ﬁ
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c
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n
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d
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p
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p
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h
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p
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c
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b
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d
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c
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)
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p
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h
e
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d
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b
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i
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i
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v
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P
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e
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b
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c
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i
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p
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c
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c
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b
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c
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c
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c
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ﬁ
s
h
a
l
l
o
w
e
d
f
o
r
t
h
e
A
I
o
f
E
P
A
+
D
H
A
w
h
i
l
e
r
e
m
a
i
n
i
n
g
b
e
l
o
w
t
h
e
T
D
I
.
H
i
g
h
e
r
p
e
r
c
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h
e
r
s
(
2
0
0
7
)
7
0
-
k
g
a
d
u
l
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c
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c
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c
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ﬁ
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i
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c
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u
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d
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b
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c
a
t
e
g
o
r
i
e
s
,
e
x
c
e
p
t
t
h
a
t
P
A
H
s
e
x
p
o
s
u
r
e
r
e
s
u
l
t
e
d
i
n
a
n
i
n
c
r
e
a
s
e
d
c
a
n
c
e
r
r
i
s
k
o
f
2
.
4
×
1
0
−
5
D
o
m
i
n
g
o
a
n
d
o
t
h
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u
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r
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p
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n
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d
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c
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c
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c
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b
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b
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p
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i
e
t
a
r
y
e
x
p
o
s
u
r
e
a
n
d
i
n
t
a
k
e
l
e
v
e
l
s
b
a
s
e
d
o
n
f
o
o
d
f
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u
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c
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p
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r
s
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2
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o
t
a
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.
S
.
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p
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p
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ﬁ
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n
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u
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n
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ﬁ
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p
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ﬁ
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n
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r
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t
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H
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i
t
y
a
n
d
s
t
r
o
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;
c
h
a
n
g
e
i
n
I
Q
p
o
i
n
t
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Q
A
L
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a
d
j
u
s
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e
d
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o
s
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r
e
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o
n
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e
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o
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l
i
n
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e
x
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n
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c
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ﬁ
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c
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0
0
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p
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c
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d
b
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b
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ﬁ
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o
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r
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ﬁ
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g
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ﬁ
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M
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+
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0
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A
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+
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1
I
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n
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h
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h
e
r
s
(
2
0
0
5
a
)
F
r
e
n
c
h
a
d
u
l
t
s
c
o
n
s
u
m
i
n
g
h
i
g
h
a
m
o
u
n
t
s
o
f
ﬁ
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ﬁ
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t
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o
p
u
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s
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H
g
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c
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p
o
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P
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D
H
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H
D
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d
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b
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;
i
m
p
a
c
t
o
n
I
Q
p
o
i
n
t
s
Q
A
L
Y
-
a
d
j
u
s
t
e
d
d
o
s
e
-
r
e
s
p
o
n
s
e
m
o
d
e
l
i
n
g
e
x
a
m
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n
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n
g
e
f
f
e
c
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o
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i
n
c
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H
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t
a
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e
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3
9
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2
7
0
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g
/
d
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h
r
o
u
g
h
ﬁ
s
h
c
o
n
s
u
m
p
t
i
o
n
B
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n
e
ﬁ
c
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a
l
e
f
f
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c
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o
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c
r
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s
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n
g
E
P
A
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H
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n
t
a
k
e
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h
r
o
u
g
h
ﬁ
s
h
c
o
n
s
u
m
p
t
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o
n
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w
i
t
h
Q
A
L
Y
s
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o
t
a
l
i
n
g
9
7
2
4
8
t
o
2
8
5
7
7
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,
d
e
p
e
n
d
i
n
g
o
n
t
h
e
d
o
s
e
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r
e
s
p
o
n
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e
m
o
d
e
l
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C
o
n
ﬁ
d
e
n
c
e
i
n
t
e
r
v
a
l
i
n
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i
c
a
t
e
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p
o
s
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i
b
l
e
n
e
g
a
t
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v
e
e
f
f
e
c
t
s
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r
o
m
M
e
H
g
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o
r
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o
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e
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n
d
i
v
i
d
u
a
l
s
.
G
u
e
v
e
l
a
n
d
o
t
h
e
r
s
(
2
0
0
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)
U
.
S
.
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o
u
s
e
h
o
l
d
s
w
i
t
h
p
r
e
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n
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c
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c
u
r
y
I
m
p
a
c
t
o
n
I
Q
p
o
i
n
t
s
/
c
h
i
l
d
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n
d
c
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r
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p
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n
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,
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o
t
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l
ﬁ
s
h
c
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s
u
m
p
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m
p
a
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Q
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o
i
n
t
s
/
c
h
i
l
d
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r
e
d
u
c
t
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o
n
o
f
C
H
D
-
r
e
l
a
t
e
d
d
e
a
t
h
s
a
n
d
c
o
r
r
e
s
p
o
n
d
i
n
g
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n
e
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r
y
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s
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a
l
c
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l
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o
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l
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h
i
m
p
a
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o
d
p
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r
c
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h
o
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A
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s
2
0
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r
c
u
r
y
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ﬁ
s
h
a
d
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i
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e
s
u
l
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u
c
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ﬁ
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n
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e
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c
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l
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a
l
u
e
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a
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e
g
a
t
i
v
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0
U
S
D
2
0
0
7
S
h
i
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h
a
c
k
a
n
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W
a
r
d
(
2
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)
c   2012 Institute of Food Technologists® Vol. 11, 2012  Comprehensive Reviews in Food Science and Food Safety 515Risk-beneﬁt analysis of seafood consumption...
T
a
b
l
e
A
3
–
Q
u
a
l
i
t
a
t
i
v
e
r
i
s
k
-
b
e
n
e
ﬁ
t
a
s
s
e
s
s
m
e
n
t
s
.
T
a
r
g
e
t
S
e
a
f
o
o
d
R
i
s
k
B
e
n
e
ﬁ
c
i
a
l
B
e
n
e
ﬁ
t
p
o
p
u
l
a
t
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n
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y
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e
H
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z
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r
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n
d
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o
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t
s
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c
t
o
r
s
e
n
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p
o
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n
t
s
M
e
t
h
o
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o
f
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n
a
l
y
s
i
s
R
e
s
u
l
t
s
/
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o
n
c
l
u
s
i
o
n
s
R
e
f
e
r
e
n
c
e
A
l
l
G
e
n
e
r
a
l
M
e
H
g
,
o
t
h
e
r
m
e
t
a
l
s
,
P
O
P
s
,
m
i
c
r
o
b
s
,
s
e
a
f
o
o
d
a
l
l
e
r
g
e
n
s
a
n
d
n
a
t
u
r
a
l
l
y
o
c
c
u
r
r
i
n
g
t
o
x
i
n
s
M
e
H
g
w
a
s
t
h
e
g
r
e
a
t
e
s
t
c
o
n
c
e
r
n
,
P
O
P
s
r
e
m
a
i
n
u
n
c
e
r
t
a
i
n
E
P
A
+
D
H
A
B
e
n
e
ﬁ
t
s
t
o
w
o
m
e
n
d
u
r
i
n
g
p
r
e
g
n
a
n
c
y
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d
u
r
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o
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o
f
g
e
s
t
a
t
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o
n
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n
d
b
i
r
t
h
w
e
i
g
h
t
,
i
n
f
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n
t
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n
d
c
h
i
l
d
d
e
v
e
l
o
p
m
e
n
t
,
c
a
r
d
i
o
v
a
s
c
u
l
a
r
d
i
s
e
a
s
e
,
c
a
r
d
i
o
v
a
s
c
u
l
a
r
m
o
r
t
a
l
i
t
y
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a
n
d
a
l
l
-
c
a
u
s
e
m
o
r
b
i
d
i
t
y
a
n
d
m
o
r
t
a
l
i
t
y
.
4
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p
a
r
t
q
u
a
l
i
t
a
t
i
v
e
p
r
o
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o
c
o
l
i
n
v
o
l
v
i
n
g
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i
d
e
n
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i
ﬁ
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a
t
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o
n
o
f
t
h
e
m
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n
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p
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c
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ﬁ
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p
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c
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c
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b
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e
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c
u
l
a
r
d
i
s
e
a
s
e
m
a
y
b
e
n
e
ﬁ
t
f
r
o
m
s
e
a
f
o
o
d
h
i
g
h
i
n
E
P
A
+
D
H
A
p
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e
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p
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)
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)
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,
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c
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l
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,
a
n
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s
u
d
d
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n
d
e
a
t
h
E
v
a
l
u
a
t
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o
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o
f
s
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u
d
i
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a
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l
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m
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c
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n
d
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l
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h
e
b
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f
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n
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b
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c
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p
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c
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p
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c
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l
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l
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d
M
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H
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P
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u
r
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s
N
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u
r
o
d
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v
e
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o
p
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e
n
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,
c
a
r
d
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o
v
a
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c
u
l
a
r
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c
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c
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p
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p
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p
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c
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a
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ﬁ
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t
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s
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n
d
b
e
n
e
ﬁ
t
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o
f
s
e
a
f
o
o
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c
o
n
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u
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o
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O
v
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r
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l
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:
g
o
o
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u
r
c
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o
f
n
u
t
r
i
e
n
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o
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e
r
s
C
H
D
.
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o
e
v
i
d
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c
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o
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H
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r
o
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M
e
H
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o
r
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a
n
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r
o
m
d
l
P
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B
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w
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r
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b
e
l
o
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C
H
D
b
e
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.
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m
e
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k
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o
w
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o
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p
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p
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.
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a
t
e
r
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o
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d
l
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B
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t
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k
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i
s
b
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I
n
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u
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v
e
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p
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g
l
i
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i
b
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.
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e
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o
m
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a
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o
n
s
:
b
e
n
e
ﬁ
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o
f
s
e
a
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o
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o
n
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H
D
m
o
r
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a
l
i
t
y
a
n
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i
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p
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v
i
n
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o
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v
e
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p
m
e
n
t
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E
C
F
A
F
A
O
/
W
H
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(
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)
A
l
l
A
m
e
r
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c
a
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A
l
l
s
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a
f
o
o
d
P
O
P
s
,
M
e
H
g
E
P
A
+
D
H
A
E
P
A
+
D
H
A
a
n
d
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s
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o
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+
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n
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c
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o
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p
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Appendix B: Abbreviations/Acronyms.
AHA: American Heart Association
AI: adequate intake (The Netherlands)
AHRQ: Agency for Health Research and Quality
AL: action level
ALA: alpha-linolenic acid
ASTDR: Agency for Toxic Substances of Disease Registry
BMD: benchmark dose
BMDL: benchmark dose lower bound
Cd: cadmium
CHD: coronary heart disease
CPF: cancer potency factor
CSF: cancer slope factor
CVD: cardiovascular disease
CFSII: USDA Continuing Survey of Food Intake by Individuals
CO: chronic oral
DALY: disability-adjusted life years
DDT: dichlorodiphenyltrichloroethane
DGAC: Dietary Guidelines Advisory Committee
DHA: docosahexaenoic acid
dl PCB: dioxin-like polychlorinated biphenyls
DRI: dietary reference intake
EC: European Commission
EFSA: European Food Safety Authority
EPA: eicosapentaenoic acid
EPA: U.S. Environmental Protection Agency
EU: European Union
EUML: European Union maximum level
EVT: extreme value theory
FAO: Food & Agriculture Organization of the United Nations
FDA: U.S. Food and Drug Administration
GL: guidance level
HC: Health Canada
HCB: hexachlorobenzene
HCN: Health Council of The Netherlands
HHS: U.S. Department of Health and Human Services
IOM: Institute of Medicine
INRA: Institute for Agronomy Research (France)
ISSFAL: International Society for the Study of Fatty Acids and Lipids
JECFA: Joint FAO/WHO Expert Committee on Food Additives
MeHg: methylmercury
MI: myocardial infarction
ML: maximum level
MRL: minimal risk level
mt: metric ton
NHANES: National Health and Nutrition Survey
NMFS: National Marine Fisheries Service
NRC: National Research Council
NOAA: National Oceanic and Atmospheric Administration
NOEL: no observed effect level
PAH: polycyclic aromatic hydrocarbon
PBDE: polybrominated diphenyl ether
PCB: polychlorinated biphenyl
PCDD: polychlorinated dibenzo dioxin
PCDE: polychlorinated diphenyl ether
PCDF: polychlorinated dibenzo furan
PCN: polychlorinated naphthalene
PMTDI: provisional maximum tolerable daily intake
POP: persistent organic pollutant
PTDI: provisional tolerable daily intake
PTMI: provisional tolerable monthly intake
PTWI: provisional tolerable weekly intake
PUFA: polyunsaturated fatty acid
QALY: quality-adjusted life years
RCT: randomized controlled trail
RDA: recommended daily allowance
RDI: reference daily intake
RfD: reference dose
SACN/COT: Scientiﬁc Advisory Committee on Nutrition/Committee on Toxicity (UK)
SCF: Scientiﬁc Committee on Food (France)
TCDD: 2,3,7,8-tetrachlorodibenzo-p-dioxin
TDI: tolerable daily intake
TEF: toxic equivalent factor
TEQ: total dioxin-like equivalency
TL: tolerance level
USDA: U.S. Department of Agriculture
VRM: visual recognition memory
WAPM: World Association of Perinatal Medicine
WHO: World Health Organization
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